0001903596-24-000339.txt : 20240520 0001903596-24-000339.hdr.sgml : 20240520 20240520172104 ACCESSION NUMBER: 0001903596-24-000339 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 44 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LUDWIG ENTERPRISES, INC. CENTRAL INDEX KEY: 0001960262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 611133438 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41881 FILM NUMBER: 24965911 BUSINESS ADDRESS: STREET 1: 3160 NW 1 AVENUE CITY: POMPANO BEACH STATE: FL ZIP: 33064 BUSINESS PHONE: 786-235-9026 MAIL ADDRESS: STREET 1: 3160 NW 1 AVENUE CITY: POMPANO BEACH STATE: FL ZIP: 33064 10-Q 1 ludg_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.

FORM 10-Q

[X]

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2024

[ ]

Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________ to ________

Commission File No. 333-271439

Ludwig Enterprises, Inc.

(Exact name of registrant as specified in its charter)

Nevada

(State or Other Jurisdiction of Incorporation or Organization)

61-1133438

(IRS Employer Identification No.)

1749 Victorian Avenue, #C-350, Sparks, Nevada 89431

(Address of Principal Executive Offices, Including Zip Code)

786-235-9026

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities Registered under Section 12(b) of the Exchange Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ ] No [X]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]	Smaller reporting company [X]
Non-accelerated filer [X]		Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

The number of shares outstanding of the registrant’s Common Stock, $.001 par value (being the only class of its common stock), is 159,019,808 as of May 20, 2023.

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements


		Page

Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2023 (audited)		3

Unaudited Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and 2023		4

Unaudited Consolidated Statements of Changes in Stockholders' Deficit for the Three Months Ended March 31, 2024 and 2023		5

Unaudited Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023		6

Notes to Unaudited Financial Statements		7 - 14

Ludwig Enterprises, Inc.

Consolidated Balance Sheets

(Unaudited)


	March 31,			December 31,
	2024			2023
Assets		(Unaudited)
Current Assets
Cash	$	345,470		$	108,335
Prepaid expenses		4,133			4,133
Total Current Assets		349,603			112,468

Total Assets	$	349,603		$	112,468

Liabilities and Stockholders' Deficit
Current Liabilities
Accounts payable and accrued liabilities	$	279,159		$	204,024
Notes payable		1,270,009			1,270,009
Convertible notes payable, net		398,000			100,000
Advances		50,000			—
Total Current Liabilities		1,997,168			1,574,033

Total Liabilities		1,997,168			1,574,033

Stockholders' Deficit
Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding		7,000			7,000
Common stock: 1,250,000,000 authorized; $0.001 par value, 155,464,808 and 155,464,808 shares issued and outstanding, respectively		155,463			155,463
Common stock issuable		747,750			—
Additional paid in capital		3,295,584			2,618,454
Accumulated deficit		(5,853,362	)		(4,242,482	)
Total Stockholders' Deficit		(1,647,565	)		(1,461,565	)
Total Liabilities and Stockholders' Deficit	$	349,603		$	112,468

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Ludwig Enterprises, Inc.

Consolidated Statements of Operations

(Unaudited)


	Three Months Ended March 31,
	2024			2023

Revenues	$	13,047		$	—

Operating expenses
General and administration expenses		368,180			410,504
Research and development		42,982			410,016
Total operating expenses		411,162			820,520

Net loss from operations		(398,115	)		(820,520	)

Other income (expense)
Inducement expense		(520,000	)		—
Finance expense		(677,130	)
Interest expense		(7,635	)		(2,572	)
Amortization of debt discount		(8,000	)		(152,737	)
Total other income (expense)		(1,212,765	)		(155,309	)

Net loss before taxes		(1,610,880	)		(975,829	)

Income tax benefit		—			—

Net loss	$	(1,610,880	)	$	(975,829	)

Basic and diluted loss per common share	$	(0.01	)	$	(0.00	)

Weighted average number of common shares outstanding, basic and diluted		155,464,808			316,055,485

The accompanying notes are an integral part of these unaudited consolidated financial statements.

Ludwig Enterprises, Inc.

Consolidated Statements of Changes in Stockholders’ Deficit

For the Three Months Ended March 31, 2024

(Unaudited)


	Convertible Preferred Stock				Common Stock				Common Stock Issuable				Additional Paid in		Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Total

Balance, December 31, 2023		7,000,000	$	7,000		155,464,808	$	155,463		—	$	—	$	2,618,454	$	(4,242,482	)	$	(1,461,565	)

Common stock issuable for services		—		—		—		—		1,475,000		227,500		—		—			227,750
Common stock issuable for note extension included in inducement expense		—		—		—		—		2,080,000		520,000		—		—			520,000
Warrant issued for commitment fee		—		—		—		—		—		—		677,130		—			677,130
Net loss		—		—		—		—		—		—		—		(1,610,880	)		(1,610,880	)
Balance, March 31, 2024		7,000,000	$	7,000		155,464,808	$	155,463		3,555,000	$	747,750	$	3,295,584	$	(5,853,362	)	$	(1,647,565	)

For the Three Months Ended March 31, 2023


	Convertible								Additional
	Preferred Stock				Common Stock				Paid in		Accumulated
	Shares		Amount		Shares		Amount		Capital		Deficit			Total

Balance, December 31, 2022		7,000,000	$	7,000		315,188,929	$	315,188	$	637,577	$	(1,785,932	)	$	(826,167	)

Stock issued for license fee		—		—		1,000,000		1,000		369,000		—			370,000
Stock issued for services		—		—		490,000		490		175,910		—			176,400
Net loss		—		—		—		—		—		(975,829	)		(975,829	)
Balance, March 31, 2023		7,000,000	$	7,000		316,678,929	$	316,678	$	1,182,487	$	(2,761,761	)	$	(1,255,596	)

The accompanying unaudited notes are an integral part of these unaudited consolidated financial statements

Ludwig Enterprises, Inc.

Consolidated Statements of Cash Flows

(Unaudited)


	Three Months Ended March 31,
	2024			2023
Cash Flows from Operating Activities:
Net loss	$	(1,610,880	)	$	(975,829	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock issuable for services		227,750			176,400
Stock warrants issued for finance cost		677,130			370,000
Amortization of debt discount		8,000			152,737
Inducement expense		520,000			—
Changes in operating assets and liabilities:
Deposit		—			(23,865	)
Accounts payable and accrued liabilities		75,135			2,672
Net Cash Used in Operating Activities		(102,865	)		(297,885	)
Cash Flows from Financing Activities:
Proceeds from convertible notes payable - net		290,000			70,000
Cash advance from investor		50,000			—
Net Cash Provided by Financing Activities		340,000			70,000
Net change in cash		237,135			(227,885	)
Cash, beginning of period		108,335			516,195
Cash, end of period	$	345,470		$	288,310
Supplemental cash flow information:
Cash paid for interest	$	—		$	—
Cash paid for taxes	$	—		$	—
Supplemental disclosure of non-cash financing activity
Original issuance debt and guaranteed interest as debt discount	$	15,000		$	30,000

The accompanying unaudited notes are an integral part of these unaudited consolidated financial statements.

LUDWIG ENTERPRISES, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

Note 1–- Organization and Nature of Operations

Organization and Nature of Operations

Ludwig Enterprises, Inc. (collectively, “we,” “us,” “our” or the “Company”), a Nevada Corporation (incorporated February 2006).

The Company is currently seeking to develop products and services through the use of cutting-edge technologies in the health care industry.

Formation of Subsidiaries

On May 18, 2022, the Company formed mRNA for Life, Inc. (“mRNA”), a Wyoming corporation, which is a wholly-owned subsidiary of the Company. mRNA is expected to produce supplements to address clinical diagnoses from mRNA cheek swabs.

On November 18, 2022, the Company formed Precision Genomics, Inc. (“PGI”), a Wyoming corporation, which is a wholly-owned subsidiary of the Company. PGI will be developing proprietary medical artificial intelligence (“AI”) technology that uses mRNA inflammatory language to potentially capture an inflammatory snapshot of disease and the body’s response to treatment.

On June 6, 2023, the Company formed Exousia Ai, Inc. (“EXO”), a Wyoming corporation, which is a wholly-owned subsidiary of the Company. EXO was formed to focus on studying the expression of differentially expressed mRNA genes in various chronic inflammatory diseases.

Liquidity, Going Concern and Management’s Plans

These financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.

As reflected in the accompanying financial statements, for the three months ended March 31, 2024, the Company had:

●

Net loss of $1,610,880; and

●

Net cash used in operations was $102,865

Additionally, at March 31, 2024, the Company had:

●

Accumulated deficit of $5,853,362

●

Stockholders’ deficit of $1,647,565; and

●

Working capital deficit of $1,647,565

The Company has cash on hand of $345,470 at March 31, 2024. The Company does not expect to generate sufficient revenues and positive cash flows from operations to meet its current obligations. However, the Company may seek to raise debt or equity-based capital at favorable terms, though such terms are not certain.

These factors create substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period subsequent to the date that these financial statements are issued.

The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

Management’s strategic plans include the following:

●

Execute business operations more fully during the year ended December 31, 2024,

●

Seek out strategic acquisitions of health care technology; and

●

Explore prospective partnership opportunities

Note 2–- Summary of Significant Accounting Policies

Basis of Presentation

The Company prepares its financial statements in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and accordance with accounting principles generally accepted in the United States of America (“GAAP”). The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these unaudited interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended December 31, 2023, contained in the Company’s Form 10-K filed with the SEC on April 16, 2023.

Principles of Consolidation

These consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of the Company and its wholly owned subsidiaries mRNA and EXO. All intercompany transactions and balances have been eliminated.

Use of Estimates

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.

Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances.

Significant estimates during the three months ended March 31, 2024 and 2023 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.

Fair Value of Financial Instruments

The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements. ASC 820 provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value.

The three tiers are defined as follows:

●

Level 1–- Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

●

Level 2–- Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

●

Level 3–-Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist us in determining fair value, as appropriate.

Although the Company believes that the recorded fair value of our financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.

The Company’s financial instruments are carried at historical cost. At March 31, 2024 and December 31, 2023, respectively, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.

ASC 825-10 ”Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (“fair value option”). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding financial instruments.

Cash and Cash Equivalents and Concentration of Credit Risk

For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents.

At March 31, 2024 and December 31, 2023, respectively, the Company did not have any cash equivalents.

The Company is exposed to credit risk on its cash and cash equivalents in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000.

At March 31, 2024 and December 31, 2023, the Company’s cash balances exceeded FDIC insured limits by $45,000 and $0, respectively. The Company did not have any losses on cash in excess of the insured FDIC limit.

Revenue recognition

Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

identify the contract with a customer;

identify the performance obligations in the contract;

determine the transaction price;

allocate the transaction price to performance obligations in the contract; and

recognize revenue as the performance obligation is satisfied.

Research and Development

The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”).

Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred.

The Company incurred research and development expenses of $42,982 and $410,016 for the three months ended March 31, 2024 and 2023, respectively.

Advertising Costs

Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations.

The Company recognized $10,451 and $69,856 in marketing and advertising costs during the three months ended March 31, 2024 and 2023, respectively.

Stock-Based Compensation

The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options and common stock warrant.

The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

When determining fair value, the Company considers the following assumptions in the Black-Scholes model:

●

Exercise price,

●

Expected dividends,

●

Expected volatility,

●

Risk-free interest rate; and

●

Expected life of option

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

Basic and Diluted Earnings (Loss) per Share

Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible preferred stock, convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future.

At March 31, 2024 and 2023, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity securities:

Potentially dilutive equity securities

	March 31, 2024		December 31, 2023

Convertible Preferred Stock		700,000,000		700,000,000
Warrant		2,604,667		—

Each share of preferred stock (7,000,000 shares) is convertible into 100 shares of common stock.

New Accounting Standard Adopted

In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year.

In June 2022, the FASB issued ASU 2022-03, ASC Subtopic “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. These amendments clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments in this update are effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements.

This guidance was adopted on January 1, 2024. The adoption of ASU 2022-03 did not have a material impact on the Company's consolidated financial statements.

Note 3 – Notes Payable and Convertible Notes Payable

Notes Payable - Net

Notes payable are summarized as follows:

Summary of notes payable

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
June 2012	July 2024	8%	Unsecured	$	6,240	$	6,240
May 2014	July 2024	8%	Unsecured		3,456		3,456
June 2016	July 2024	8%	Unsecured		38,216		38,216
January 2017	July 2024	8%	Unsecured		7,344		7,344
November 2020	July 2024	12%	Unsecured		46,480		46,480
March 2021	July 2024	8%	Unsecured		5,400		5,400
November 2021	July 2024	0%	Unsecured		250,000		250,000
February 2022	July 2024	0%	Unsecured		150,000		150,000
August 2023	August 2024	8%	Unsecured		122,873		122,873
January 2023 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
October 2022 ⁽¹⁾	July 2024	0%	Unsecured		440,000		440,000
November 2022 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
			Notes payable	$	1,270,009	$	1,270,009

(1)	In November 2023, the convertible notes were amended to remove the conversion features and the Company reclassified $640,000 from convertible notes to notes payable.

Convertible Notes Payable - Net

The Company had the following activity related to its convertible notes payable:

Convertible notes payable, net


Balance - December 31, 2023	$	100,000
Proceeds (face amount of note)		300,000
Guaranteed Interest recorded to convertible note payable		5,000
Original issue debt discount		(10,000	)
Guaranteed interest – debt discount		(5,000	)
Amortization of debt discount		8,000
Balance – March 31, 2024	$	398,000

Convertible Notes Payable are summarized as follows:

Summary Of Convertible Notes Payable

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
October 2023	October 2024	8%	Unsecured	$	100,000		100,000
February 2024	May 2024	10%	Unsecured		55,000		-
March 2024	March 2025	8%	Unsecured		150,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
				$	405,000	$	100,000
			Less: unamortized debt discount		(7,000)		-
			Convertible notes payable – net		398,000	$	100,000

Notes Issued in 2024

In February, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated February 12, 2024, in the principal amount of $50,000. The Note was funded by the Investor on February 15, 2024, with the Company receiving funding of $40,000, net of OID of $15,000, including guaranteed interest of 10% per calendar year, or $5,000. The Note matures on May 12, 2024. Only upon an event of default that shall not have been cured, the Note is convertible into shares of the Company’s common stock at any time at a conversion price equal to the lowest traded price of the Common Stock during the thirty (30) business days prior to the relevant notice of conversion; provided, however, that the Investor may not convert the Note to the extent that such conversion would result in the investor’s beneficial ownership of the Company’s common stock being in excess of 9.99% of the Company’s then-issued and outstanding common stock.

On March 28, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated March 31, 2024, in the principal amount of $150,000 with an interest rate of 8% per annum. The Note matures on March 31,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

On March 28, 2024, the Company entered into a second securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated March 31, 2024, in the principal amount of $50,000 with an interest rate of 8% per annum. The Note matures on March 31,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

Inducements

In March 2024, the Company recorded 2,080,000 shares of common stock issuable as inducements to 7 individuals for the extension of 7 promissory notes to July 1, 2024, which shares were valued at $0.25 per share. The Company recorded $520,000 as inducement expense.

Note 4 – Commitments and Contingencies

On September 5, 2023, we entered into an employment agreement with Marvin S. Hausman, M.D., pursuant to which Dr. Hausman serves as our Chief Executive Officer. Under his employment agreement, we will pay Dr. Hausman $5,000 per month. In addition, we will pay Dr. Hausman an amount equal to 10% of gross sales revenues attributable to Dr. Hausman’s efforts, in perpetuity.

On September 5, 2023, we entered into an employment agreement with Thomas Terwilliger, pursuant to which Mr. Terwilliger serves as our Chief Operating Officer, Treasurer and Secretary. Under his employment agreement, we will pay Mr. Terwilliger $5,000 per month. In addition, we will pay Mr. Terwilliger an amount equal to 10% of gross sales revenues attributable to Mr. Terwilliger’s efforts, in perpetuity. On November 28, 2023, Mr. Terwilliger resigned as Chief Operating Officer, but continues to provide limited services to the company on an outsourced basis.

On November 15, 2023, we entered into a Financial Advisory Services Agreement with EverAsia Financial Group, Inc., a financial consulting firm owned by Scott J. Silverman, who, in conjunction with the execution the CFO Agreement, was appointed as our Chief Financial Officer. Under the CFO Agreement, the Company is obligated to make monthly payments of $8,750, as follows:

Beginning from the execution date of the CFO Agreement and continuing until the Company raises $750,000 in equity or debt financing (the “Accrual Period”), the Company is obligated to make the monthly payments described in the following table:

Schedule of monthly payment

Funds Raised	Paid Monthly	Accrued Monthly
$0 – $250,000	$3,750	$5,000
$250,000 – $750,000	$5,000	$3,750

Upon the Company’s raising of $750,000, it shall pay the accrued amount in cash. Thereafter, the Company

shall pay the entire monthly payment without accrual.

Note 5 – Stockholders’ Deficit

The Company has two (2) classes of stock:

Common Stock

●

1,250,000,000 shares authorized

●

$0.001 par value

●

Voting at 1 vote per share

Preferred Stock

In May 2022 and December 2022, the Company’s Articles of Incorporation, as amended, authorized the issuance of 7,000,000 shares of preferred stock which may be amended from time to time in one or more series. The Board of Directors is authorized to determine, prior to issuing any such series of preferred stock and without any vote or action by the shareholders, the rights, preferences, privileges and restrictions of the shares of such series, including dividend rights, voting rights, terms of redemption, the provisions of any purchase, retirement or sinking fund to be provided for the shares of any series, conversion and exchange rights, the preferences upon any distribution of the assets of the Company, including in the event of voluntary or involuntary liquidation, dissolution or winding up of the Company, and the preferences and relative rights among each series of preferred stock.

The Board of Directors has made the following designations of its preferred stock.

Series A, Convertible Preferred Stock

●

7,000,000 shares authorized.

●

$0.001 par value.

●

Conversion feature–-each share of preferred stock is convertible into 100 shares of common stock.

●

Voting–-on an as converted basis with common stock, at the applicable conversion rate (100 votes for each share of convertible preferred held).

●

Dividends–-accrued only upon declaration of the board of directors, at the applicable conversion rate.

●

Mandatorily redeemable (automatic conversion) on January 1, 2025. (See below amendment)

●

Anti-dilution provision – rights exist for the period of two years after the convertible preferred shares were converted into common stock. Additionally, holders of the convertible preferred stock will have full ratchet anti-dilution protection rights at the rate of 65% calculated on a fully diluted basis. (See below amendment)

In connection with the issuance of these Series A, convertible preferred shares, the Company determined that there were no provisions within ASC 815 that were met, which would require derivative liability accounting treatment. Specifically, as noted below, upon amending the terms of the Series A, convertible preferred stock, at that time, there had been no new stock issuances of any type which may have triggered the anti-dilution provision.

In December 2022, the Company amended its articles of incorporation related to certain terms of its Series A, convertible preferred stock. At that time, the Company, along with approval from its convertible preferred stockholders agreed to remove provisions related to mandatory redemption as well as anti-dilution rights.

At March 31, 2024 and December 31, 2023, the Company had 7,000,000 shares issued and outstanding. See below for related issuances.

Equity Transactions for fiscal year 2024

During the three months ended March 31, 2024, the Company recorded 3,555,000 shares of common stock issuable as follows:

●

225,000 shares of common stock to three individuals as bonuses for their services valued at $0.29 per share, the closing price on the date of issue as quoted on OTCMarkets.com, for a total of $65,250.

●

1,250,000 shares of common stock to an individual for his services. Such shares of common stock were issued as compensation (250,000 shares pursuant to a consulting agreement and 1,000,000 shares as a performance bonus) valued at $0.13 per share, the closing price on the date of issue as quoted on OTCMarkets.com, for a total of $162,500.

●

2,080,000 shares of common stock as inducements to enter into promissory notes with the Company, valued at $0.25 per share, the closing price on the date of issue as quoted on OTCMarkets.com, for a total of $520,000

Securities Purchase Agreement

On February 12, 2024, the Company entered into a Common Stock Purchase Agreement (the “Purchase Agreement”), together with a registration rights agreement (the “Registration Rights Agreement”) with an institutional investor (the “Investor”), pursuant to which the Company has the right to sell to the Investor up to $5,000,000 in shares of its common stock (“Common Stock”), subject to certain limitations. The Investor was also issued a five-year warrant (the “Warrant”) to purchase 2,604,667 shares of Common Stock (the “Warrant Shares”) with standard anti-dilution provisions and cashless exercise.

Under the terms and subject to the conditions of the Purchase Agreement, the Investor is obligated to purchase up to $5,000,000 in shares of Common Stock (subject to certain limitations) from time to time over the period commencing on the date of the Purchase Agreement and ending on June 30, 2025. The price per share of Common Stock shall be eighty percent (80%) of the lowest traded price of the Common Stock for the six trading days following the closing date associated with the purchase notice delivered by the Company to the Investor. The maximum amount of each purchase notice shall be the lesser of (a) $250,000 or (b) two hundred fifty percent (250%) of the average daily trading volume during the six business days prior to the date associated with the purchase notices delivered by the Company to the Investor.

The Company’s sales of shares of Common Stock to the Investor under the Purchase Agreement are limited to no more than the number of shares that would result in the beneficial ownership by the Investor and its affiliates, at any single point in time, of more than 4.99% of the then-outstanding shares of the Common Stock; provided, however, that the Investor may increase the beneficial ownership limitation up to 9.99%, at its sole discretion, upon sixty-one (61) days’ prior written notice to the Company.

The Company agreed with the Investor that it will not enter into any other equity line or similar agreements without the prior consent of the Investor.

Pursuant to the terms of the Registration Rights Agreement, the Company shall file a registration statement with the SEC with respect to the shares of Common Stock issuable to the Investor pursuant to the Purchase Agreement and the Warrant Shares within 20 calendar days.

The Purchase Agreement and the Registration Rights Agreement contain customary representations, warranties and agreements of the Company and the Investor and customary conditions to completing future sale transactions, indemnification rights and obligations of the parties.

The Company has not sold any shares to the Investor as of March 31, 2024.

Note 6 – Warrants

In February 2024, the Company issued 2,604,667 warrants in connection with the Purchase Agreement (Note 5), valued at $677,130. The Warrants expire five (5) years from the date of issuance. The warrants were earned and issued without recourse upon signature of the Purchase Agreement (Note 5),and recorded as a finance expense. The exercise price per warrant shall be calculated by dividing $30,000,000 by the total number of outstanding shares of common stock as of the exercise date.

A summary of activity of the warrants during the three months ended March 31, 2024, is follows:

Summary of activity of the warrants

	Number of		Weighted average	Weighted average
	Warrant		Exercise price	Remaining life (year)
Outstanding at December 31, 2023	-	$	-	-
Grant	2,604,667		0.19	5.00
Exercised	-		-	-
Cancelled	-		-	-
Outstanding at March 31, 2024	2,604,667	$	0.19	4.87

The intrinsic value of the warrants as of March 31, 2024, is $148,545. All of the outstanding warrants are exercisable as of March 31, 2024.

Valuation

The Company utilizes the Black-Scholes model to value its warrants. The Company utilized the following assumptions:

Valuation assumptions


	Three months ended
	March 31, 2024
Expected term		5 years
Expected average volatility		338	%
Expected dividend yield		—
Risk-free interest rate		4.13	%

Note 7 – Subsequent Events

On April 1, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated April 1, 2024, in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on April,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

On April 1, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated April 1, 2024, in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on April 1,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

On May 9, 2024, the Company paid the $50,000 OID Note entered into in February, 2024 together with $5,000 in guaranteed interest and retired the Note.

On May 15, 2024, the Company entered issued a Convertible Promissory Note to an investor in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on May 15, 2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

On May 16, 2024, the Company entered issued a Convertible Promissory Note to an investor in the principal amount of $100,000 with an interest rate of 8% per annum. The Note matures on May 16, 2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of our operations together with our consolidated financial statements and the notes thereto appearing elsewhere in this prospectus. This discussion contains forward-looking statements reflecting our current expectations, whose actual outcomes involve risks and uncertainties. Actual results and the timing of events may differ materially from those stated in or implied by these forward-looking statements due to a number of factors, including those discussed in the sections entitled “Risk Factors,” “Cautionary Statement Regarding Forward Looking Statements” and elsewhere herein. Please see the notes to our Financial Statements for information about our Critical Accounting Policies and Recently Issued Accounting Pronouncements.

Forward looking Statements

There are “forward looking statements” contained herein. All statements that express expectations, estimates, forecasts or projections are forward-looking statements. In addition, other written or oral statements which constitute forward-looking statements may be made by us or on our behalf. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “project,” “forecast,” “may,” “should,” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in or suggested by such forward-looking statements. We undertake no obligation to update or revise any of the forward-looking statements after the date of this quarterly report to conform forward-looking statements to actual results. Important factors on which such statements are based are assumptions concerning uncertainties, including but not limited to, uncertainties associated with the following:

_●

Inadequate capital and barriers to raising the additional capital or to obtaining the financing needed to implement our business plans;

_●

Our failure to earn revenues or profits;

_●

Inadequate capital to continue business;

_●

Volatility or decline of our stock price;

_●

Potential fluctuation in quarterly results;

_●

Rapid and significant changes in markets;

_●

Litigation with or legal claims and allegations by outside parties; and

_●

Insufficient revenues to cover operating costs.

The following discussion should be read in conjunction with the unaudited financial statements and the notes thereto which are included in this quarterly report. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ substantially from those anticipated in any forward-looking statements included in this discussion as a result of various factors.

Overview

We are an innovative technology and health related company that is developing products that use mRNA-based genetic markers with the potential to measure the presence of inflammation, and, as a result, inflammatory driven diseases and monitor patient response to treatment. Advancements in medical technology have awarded us with cutting edge genetic tools, unheard of even a generation ago. These genetic tools have the potential to not only achieve early detection of diseases but also to support customized treatments that may improve patient outcomes. Our company is at the forefront of this new era of medicine with development of products that will embody our proprietary mRNA genomic technology that has the potential of detecting genetic biomarkers for inflammatory driven diseases, including, but not limited to, heart disease, diabetes, preeclampsia, cancer and “long COVID.”

Our subsidiary, Precision Genomics, Inc., has developed medical machine learning, artificial intelligence (“AI”) technology that uses measurements of mRNA genetic biomarkers to potentially predict the presence of inflammation, and, as a result, inflammatory driven diseases and monitor patient response to treatment. Precision Genomics’ proprietary technology uses unique mRNA language to capture a snapshot of disease and the body’s response to treatment. This genomic technology is applicable to chronic inflammatory driven diseases, including, but not limited to, cancer, heart disease, diabetes, preeclampsia and “long COVID.”

Effects of COVID 19 on The Company

The COVID-19 pandemic did not have a discernable negative impact on our company, due to our lack of capital with which we operate. Overall, our company is not of a size that required us to implement “companywide” policies in response to the COVID-19 pandemic.

Current Financial Condition Summary

We have not yet derived revenues from our operations.

We had a net loss of $1,610,880 (unaudited) for the three months ended March 31, 2024. Additionally, we had net cash used in operating activities of $102,865 (unaudited) for the three months ended March 31, 2024. At March 31, 2024, we had a working capital deficit of $1,647,565 (unaudited), an accumulated deficit of $5,853,362 (unaudited) and a stockholders’ deficit of $1,647,565 (unaudited), which could have a material impact on our ability to obtain needed capital.

Results of Operations

Three months ended March 31, 2024, compared to the three months ended March 31, 2022. For the three months ended March 31, 2024 and 2023, we had revenue from services of $13,047 and $0, respectively. We expect that revenues from sales of our planned products will begin during the third quarter of 2024, assuming we are able to obtain needed funding of approximately $1,500,000, of which there is no assurance.

Operating Expenses. Total operating expenses for the three months ended March 31, 2024 and 2023, were $411,162 and $820,520, respectively. The decrease in operating expenses during the three months ended March 31, 2024, was primarily due to a significant decrease in our activities relating to research and development, as well as the reduction in payments of monthly fees to our key consultants and fees for professional services, including accounting and legal.

General and Administrative Expenses. The decrease of $42,324 in general and administrative expenses for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023, was primarily due to the decrease in our payments of monthly fees to our key consultants and fees for professional services, including accounting and legal.

Research and Development. The $42,982 and $410,016 in research and development expenses for the three months ended March 31, 2024 and 2023, respectively, were incurred due to our determining to make expenditures in the development of our planned products, including the payment of product study-relate expenses. While we expect to continue to incur research and development expenses, we are unable to predict the level of such expenditures, due to the uncertainty of the level of funding that will be available to us.

Other Income/Expense. Total other expense for the three months ended March 31, 2024 and 2023, were $1,212,765 and $155,309, respectively. The increase in total other expense during the three months ended March 31, 2024, was primarily due to a increase in inducement expense associated with our extending notes payable that had reached maturity and an issuance of warrants as a financing expense.

Amortization of Debt Discount. During the three months ended March 31, 2024, we incurred $8,000 in amortization of debt discount for OID and guaranteed interest on a convertible note payable. During the three months ended March 31, 2023, we incurred amortization of debt discount expense of $152,737. We are unable to predict with any certainty our amortization of debt discount expense for all of 2024.

Interest Expense. Interest expense for the three months ended March 31, 2024, was higher than for the three months ended March 31, 2023, $7,635 versus $2,572. We anticipate that our interest expense for all of 2024 will be higher but are unable to make any prediction in this regard.

Net Loss. We incurred a net loss of $1,610,880 for the three months ended March 31, 2024, as compared to a net loss of $975,829 for the three months ended March 31, 2023. The increase in net loss for the three months ended March 31, 2024, as compared to the three months ended March 31, 2023, was primarily due to stock-based inducement and financing expenses of $1,197,130, and reduced by a decrease of $409,358 in operating expenses, a decrease of $144,737 in amortization of debt discount and a increase in interest expense of $5,063. Should we be able to obtain needed capital, as we continue to expand our business activities, we expect that our operating expenses for all of 2024 will be in excess of those incurred during the year ended December 31, 2023. However, we are unable to predict our actual operating expenses for all of 2024, due to the uncertainty surrounding our ability to obtain capital.

Liquidity and Capital Resources

March 31, 2024. At March 31, 2024, the Company had $345,470 in cash and a working capital deficit of $1,647,565 compared to $108,335 in cash and a working capital deficit of $1,461,565 at December 31, 2023. The Company has sufficient working capital to fund current operating expenses at least through the third quarter of 2024. To the extent the Company requires additional funds beyond such time, we will need to obtain additional debt or equity-based capital from third parties to implement our full business plans. There is no assurance that we will be successful in obtaining such additional capital.

Cash Flows

Net Cash Used in Operating Activities. Net cash used in operating activities was $102,865 during the three months ended March 31, 2024, compared to $297,885 used during the three months ended March 31, 2023.

Net Cash Used in Investing Activities. Net cash used in investing activities was $-0- during the three months ended March 31, 2024, compared to $-0- during the three months ended March 31, 2023.

Net Cash Provided by Financing Activities. Net cash provided by financing activities was $340,000 of net cash during the three months ended March 31, 2024, as compared to $70,000 provided during the three months ended March 31, 2023. All of the cash provided by financing activities was proceeds from convertible promissory notes issued and an advance.

Notes Payable and Convertible Promissory Notes

On March 28, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated March 31, 2024, in the principal amount of $50,000 with an interest rate of 8% per annum. The Note matures on March 31,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

Notes payable are summarized as follows:

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
June 2012	July 2024	8%	Unsecured	$	6,240	$	6,240
May 2014	July 2024	8%	Unsecured		3,456		3,456
June 2016	July 2024	8%	Unsecured		38,216		38,216
January 2017	July 2024	8%	Unsecured		7,344		7,344
November 2020	July 2024	12%	Unsecured		46,480		46,480
March 2021	July 2024	8%	Unsecured		5,400		5,400
November 2021	April 2024	0%	Unsecured		250,000		250,000
February 2022	April 2024	0%	Unsecured		150,000		150,000
August 2023	August 2024	8%	Unsecured		122,873		122,873
January 2023 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
October 2022 ⁽¹⁾	July 2024	0%	Unsecured		440,000		440,000
November 2022 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
			Notes payable	$	1,270,009	$	1,270,009

(1)	In November 2023, the convertible notes were amended to remove the conversion features and the Company reclassified $640,000 from convertible notes to notes payable.

Convertible Notes Payable - Net

The Company had the following activity related to its convertible notes payable:

Balance - December 31, 2023	$	100,000
Proceeds (face amount of note)		300,000
Guaranteed Interest recorded to convertible note payable		5,000
Original issue debt discount		(10,000	)
Guaranteed interest – debt discount		(5,000	)
Amortization of debt discount		8,000
Balance – March 31, 2024	$	398,000

Convertible Notes Payable are summarized as follows:

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
October 2023	October 2024	8%	Unsecured	$	100,000		100,000
February 2024	May 2024	10%	Unsecured		55,000		-
March 2024	March 2025	8%	Unsecured		150,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
				$	405,000	$	100,000
			Less: unamortized debt discount		(7,000)		-
			Convertible notes payable – net		398,000	$	100,000

Advances

On March 28, 2024, an individual advanced the Company $50,000. There are no repayment terms on the advance as they are still under negotiation.

Going Concern

The unaudited consolidated financial statements included herein have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As reflected in the financial statements, we had a working capital deficit of $1,647,565 at March 31, 2024, and had a net loss of $1,610,880 (unaudited) for the three months ended March 31, 2024, which raises substantial doubt as to the Company’s ability to continue as a going concern for a period of one year from the issuance of the financial statements.

Off Balance Sheet Arrangements

At March 31, 2024, we did not have any off balance sheet arrangements that we believe have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Critical Accounting Policies

Our accounting policies are more fully described in our unaudited financial statements. The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on our best knowledge of current and anticipated events, actual results could differ from the estimates.

We have identified the following accounting policies as those that require significant judgments, assumptions and estimates and that have a significant impact on our financial condition and results of operations. These policies are considered critical because they may result in fluctuations in our reported results from period to period, due to the significant judgments, estimates and assumptions about complex and inherently uncertain matters and because the use of different judgments, assumptions or estimates could have a material impact on our financial condition or results of operations. We evaluate our critical accounting estimates and judgments required by our policies on an ongoing basis and update them as appropriate based on changing conditions.

Fair Value of Financial Instruments. The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements. ASC 820 provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

The three tiers are defined as follows:

	_●	Level 1 – Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

	_●	Level 2 – Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

	_●	Level 3 – Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

Derivative Liabilities. The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, (“ASC 480”), “Distinguishing Liabilities from Equity” and FASB ASC Topic No. 815, (“ASC 815”) “Derivatives and Hedging”. Derivative liabilities are adjusted to reflect fair value at each reporting period, with any increase or decrease in the fair value recorded in the results of operations (other income/expense) as change in fair value of derivative liabilities. The Company uses a binomial pricing model to determine fair value of these instruments.

Debt Discount. For certain notes issued, the Company may provide the debt holder with an original issue discount and other direct financing expenses. The original issue discount and financing expenses are recorded as a debt discount, reducing the face amount of the note, and is amortized to interest expense over the life of the debt, in the Consolidated Statements of Operations.

Research and Development. The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”).

Stock-based Compensation. The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options.

When determining fair value, the Company considers the following assumptions in the Black-Scholes model:

	●	Exercise price,
	●	Expected dividends,
	●	Expected volatility,
	●	Risk-free interest rate; and
	●	Expected life of option

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. Management is responsible for establishing and maintaining adequate disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in its reports filed pursuant to the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely and reliable financial reporting and the preparation of financial statements in accordance with accounting principles generally accepted in the United States of America.

As of the quarter ended March 31, 2024, our principal executive officer and principal financial officer completed an assessment of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e), to determine the existence of any material weaknesses or significant deficiencies under the Exchange Act. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the Company's financial reporting.

Based on that evaluation, we concluded that our disclosure controls and procedures over financial reporting were not effective as of March 31, 2024.

Changes in Internal Control Over Financial Reporting. There have been no changes in our internal control over financial reporting during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

We have no pending legal or administrative proceedings.

Item 1A. Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended March 31, 2024, we issue no unregistered securities that have not been reported previously.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

	Exhibit	Description
	31.1*	Certification by Registrant’s Chief Executive Officer with respect to Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024
	31.2*	Certification by Registrant’s Chief Financial Officer with respect to Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024
	32.1*	Certification pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code by Registrant’s Chief Executive Officer and Chief Financial Officer with respect to Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024

	101.*	INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
	101.SCH*	Inline XBRL Taxonomy Extension Schema Document.

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*

Inline XBRL Taxonomy Extension Labels Linkbase Document.

	101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
	104*	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

_______________________

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

LUDWIG ENTERPRISES, INC.

By: /s/ Marvin Hausman, M.D.

Marvin Hausman, M.D.

Chief Executive Officer

Dated: May 20, 2024

EX-31.1 2 ex31_1.htm

EXHIBIT 31.1

CERTIFICATION

I, Marvin Hausman, M.D., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Ludwig Enterprises, Inc. for the fiscal period ended March 31, 2024.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: May 20, 2024

By: /s/ Marvin Hausman, M.D.

Marvin Hausman, M.D

Chief Executive Officer

EX-31.2 3 ex31_2.htm

EXHIBIT 31.2

I, Scott J. Silverman, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Ludwig Enterprises, Inc. for the fiscal period ended September 30, 2023.

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: May 20, 2024

By: /s/ Scott J. Silverman

Scott J. Silverman

Chief Financial Officer [Principal Financial Officer]

EX-32.1 4 ex32_1.htm

EXHIBIT 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Marvin Hausman, M.D., certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Ludwig Enterprises, Inc. on Form 10-Q for the period ended March 31, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Ludwig Enterprises, Inc. at the dates and for the periods indicated.

Date: May 20, 2024

By: /s/ Marvin Hausman, M.D.

Marvin Hausman, M.D.

Chief Executive Officer

I, Scott J. Silverman, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Ludwig Enterprises, Inc. on Form 10-Q for the period ended March 31, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Ludwig Enterprises, Inc. at the dates and for the periods indicated.

Date: May 20, 2024

By: /s/ Scott J. Siverman

Scott J. Silverman

Chief Financial Officer [Principal Financial Officer]

A signed original of this written statement required by Section 906 has been provided to Ludwig Enterprises, Inc. and will be retained by Ludwig Enterprises, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 5 ludg-20240513.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Stockholders Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statement of Cashflows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Nature of Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Notes Payable and Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stockholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Notes Payable and Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Organization and Nature of Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Notes Payable and Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Notes Payable and Convertible Notes Payable (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Notes Payable and Convertible Notes Payable (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Warrants (Details 1) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ludg-20240513_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 ludg-20240513_def.xml XBRL DEFINITION FILE EX-101.LAB 8 ludg-20240513_lab.xml XBRL LABEL FILE Class of Stock [Axis] Convertible Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Common Stock Issuable [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Debt Instrument [Axis] Note Payable One [Member] Note Payable Two [Member] Note Payable Three [Member] Note Payable Four [Member] Note Payable Five [Member] Note Payable Six [Member] Note Payable Seven [Member] Note Payable Eight [Member] Note Payable Nine [Member] Note Payable Ten [Member] Note Payable Eleven [Member] Note Payable Twelve [Member] Convertible Notes Payable One [Member] Convertible Notes Payable Two [Member] Convertible Notes Payable Three [Member] Convertible Notes Payable Four [Member] Convertible Notes Payable Five [Member] Convertible Notes Payable Fiver [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Current Assets Cash Prepaid expenses Total Current Assets Total Assets Liabilities and Stockholders' Deficit Current Liabilities Accounts payable and accrued liabilities Notes payable Convertible notes payable, net Advances Total Current Liabilities Total Liabilities Stockholders' Deficit Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding Common stock: 1,250,000,000 authorized; $0.001 par value, 155,464,808 and 155,464,808 shares issued and outstanding, respectively Common stock issuable Additional paid in capital Accumulated deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Preferred stock, authorized Preferred stock, par value Preferred stock, issued Preferred stock, outstanding Common stock, authorized Common stock, par value Commons stock, issued Commons stock, outstanding Income Statement [Abstract] Revenues Operating expenses General and administration expenses Research and development Total operating expenses Net loss from operations Other income (expense) Inducement expense Interest expense Amortization of debt discount Total other income (expense) Net loss Income tax benefit Basic and diluted loss per common share Weighted average number of common shares outstanding, basic and diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Stock issued for services Beginning balance, shares Common stock issuable for note extension included in inducement expense Stock Issued During Period, Shares, Conversion of Convertible Securities Warrant issued for commitment fee Net loss Stock issued for license fee Beginning balance, shares Ending balance, value Beginning balance, shares Statement of Cash Flows [Abstract] Net loss Adjustments to reconcile net loss to net cash used in operating activities: Stock issuable for services Stock warrants issued for finance cost Amortization of debt discount Inducement expense Changes in operating assets and liabilities: Deposit Accounts payable and accrued liabilities Net Cash Used in Operating Activities Proceeds from convertible notes payable - net Cash advance from investor Net Cash Provided by Financing Activities Net change in cash Cash, beginning of period Cash, end of period Cash paid for interest Cash paid for taxes Supplemental disclosure of non-cash financing activity Original issuance debt and guaranteed interest as debt discount Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Nature of Operations Accounting Policies [Abstract] Summary of Significant Accounting Policies Notes Payable And Convertible Notes Payable Notes Payable and Convertible Notes Payable Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Deficit Warrants Warrants Subsequent Events Subsequent Events Basis of Presentation Principles of Consolidation Use of Estimates Fair Value of Financial Instruments Cash and Cash Equivalents and Concentration of Credit Risk Revenue recognition Research and Development Advertising Costs Stock-Based Compensation Warrants EX-101.PRE 9 ludg-20240513_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 20, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	333-271439
Entity Registrant Name	Ludwig Enterprises, Inc.
Entity Central Index Key	0001960262
Entity Tax Identification Number	61-1133438
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	1749 Victorian Avenue
Entity Address, Address Line Two	#C-350
Entity Address, City or Town	Sparks
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89431
City Area Code	786
Local Phone Number	235-9026
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		159,019,808

XML 12 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash	$ 345,470	$ 108,335
Prepaid expenses	4,133	4,133
Total Current Assets	349,603	112,468
Total Assets	349,603	112,468
Current Liabilities
Accounts payable and accrued liabilities	279,159	204,024
Notes payable	1,270,009	1,270,009
Convertible notes payable, net	398,000	100,000
Advances	50,000
Total Current Liabilities	1,997,168	1,574,033
Total Liabilities	1,997,168	1,574,033
Stockholders' Deficit
Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding	7,000	7,000
Common stock: 1,250,000,000 authorized; $0.001 par value, 155,464,808 and 155,464,808 shares issued and outstanding, respectively	155,463	155,463
Common stock issuable	747,750
Additional paid in capital	3,295,584	2,618,454
Accumulated deficit	(5,853,362)	(4,242,482)
Total Stockholders' Deficit	(1,647,565)	(1,461,565)
Total Liabilities and Stockholders' Deficit	$ 349,603	$ 112,468

XML 13 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, authorized	7,000,000	7,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, issued	7,000,000	7,000,000
Preferred stock, outstanding	7,000,000	7,000,000
Common stock, authorized	1,250,000,000	1,250,000,000
Common stock, par value	$ 0.001	$ 0.001
Commons stock, issued	155,464,808	155,464,808
Commons stock, outstanding	155,464,808	155,464,808

XML 14 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 13,047
Operating expenses
General and administration expenses	368,180	410,504
Research and development	42,982	410,016
Total operating expenses	411,162	820,520
Net loss from operations	(398,115)	(820,520)
Inducement expense	(520,000)
Interest expense	(7,635)	(2,572)
Amortization of debt discount	(8,000)	(152,737)
Total other income (expense)	(1,212,765)	(155,309)
Net loss	(1,610,880)	(975,829)
Income tax benefit
Basic and diluted loss per common share	$ (0.01)	$ (0.00)
Weighted average number of common shares outstanding, basic and diluted	155,464,808	316,055,485

XML 15 R5.htm IDEA: XBRL DOCUMENT

Statements of Stockholders Deficit (Unaudited) - USD ($)	Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock Issuable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2022	$ 7,000	$ 315,188		$ 637,577	$ (1,785,932)	$ (826,167)
Beginning balance, shares at Dec. 31, 2022	7,000,000	315,188,929
Stock issued for services		$ 490		175,910		176,400
Beginning balance, shares		490,000
Net loss					(975,829)	(975,829)
Stock issued for license fee		$ 1,000		369,000		370,000
Beginning balance, shares		1,000,000
Ending balance, value at Mar. 31, 2023	7,000	$ 316,678		1,182,487	(2,761,761)	(1,255,596)
Beginning balance, shares at Mar. 31, 2023		316,678,929
Beginning balance, value at Dec. 31, 2023	7,000	$ 155,463		2,618,454	(4,242,482)	(1,461,565)
Beginning balance, shares at Dec. 31, 2023		155,464,808
Stock issued for services			$ 227,500			227,750
Beginning balance, shares			1,475,000
Common stock issuable for note extension included in inducement expense			$ 520,000			520,000
Stock Issued During Period, Shares, Conversion of Convertible Securities			2,080,000
Warrant issued for commitment fee				677,130		677,130
Net loss					(1,610,880)	(1,610,880)
Ending balance, value at Mar. 31, 2024	$ 7,000	$ 155,463	$ 747,750	$ 3,295,584	$ (5,853,362)	$ (1,647,565)
Beginning balance, shares at Mar. 31, 2024	7,000,000	155,464,808	3,555,000

XML 16 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Cashflows - USD ($)	3 Months Ended
Consolidated Statement of Cashflows - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Statement of Cash Flows [Abstract]
Net loss	$ (1,610,880)	$ (975,829)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock issuable for services	227,750	176,400
Stock warrants issued for finance cost	677,130	370,000
Amortization of debt discount	8,000	152,737
Inducement expense	520,000
Changes in operating assets and liabilities:
Deposit		(23,865)
Accounts payable and accrued liabilities	75,135	2,672
Net Cash Used in Operating Activities	(102,865)	(297,885)
Proceeds from convertible notes payable - net	290,000	70,000
Cash advance from investor	50,000
Net Cash Provided by Financing Activities	340,000	70,000
Net change in cash	237,135	(227,885)
Cash, beginning of period	108,335	516,195
Cash, end of period	345,470	288,310
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash financing activity
Original issuance debt and guaranteed interest as debt discount	$ 15,000	$ 30,000

XML 17 R7.htm IDEA: XBRL DOCUMENT

Organization and Nature of Operations

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Nature of Operations

Note 1–- Organization and Nature of Operations

Organization and Nature of Operations

Ludwig Enterprises, Inc. (collectively, “we,” “us,” “our” or the “Company”), a Nevada Corporation (incorporated February 2006).

The Company is currently seeking to develop products and services through the use of cutting-edge technologies in the health care industry.

Formation of Subsidiaries

Liquidity, Going Concern and Management’s Plans

As reflected in the accompanying financial statements, for the three months ended March 31, 2024, the Company had:

●

Net loss of $1,610,880; and

●

Net cash used in operations was $102,865

Additionally, at March 31, 2024, the Company had:

●

Accumulated deficit of $5,853,362

●

Stockholders’ deficit of $1,647,565; and

●

Working capital deficit of $1,647,565

These factors create substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period subsequent to the date that these financial statements are issued.

Management’s strategic plans include the following:

●

Execute business operations more fully during the year ended December 31, 2024,

●

Seek out strategic acquisitions of health care technology; and

●

Explore prospective partnership opportunities

XML 18 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2–- Summary of Significant Accounting Policies

Basis of Presentation

Principles of Consolidation

Use of Estimates

Significant estimates during the three months ended March 31, 2024 and 2023 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.

Fair Value of Financial Instruments

The three tiers are defined as follows:

●

Level 1–- Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

●

Level 2–- Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

●

Level 3–-Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

Cash and Cash Equivalents and Concentration of Credit Risk

At March 31, 2024 and December 31, 2023, respectively, the Company did not have any cash equivalents.

Revenue recognition

identify the contract with a customer;

identify the performance obligations in the contract;

determine the transaction price;

allocate the transaction price to performance obligations in the contract; and

recognize revenue as the performance obligation is satisfied.

Research and Development

The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”).

The Company incurred research and development expenses of $42,982 and $410,016 for the three months ended March 31, 2024 and 2023, respectively.

Advertising Costs

Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations.

The Company recognized $10,451 and $69,856 in marketing and advertising costs during the three months ended March 31, 2024 and 2023, respectively.

Stock-Based Compensation

The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options and common stock warrant.

When determining fair value, the Company considers the following assumptions in the Black-Scholes model:

●

Exercise price,

●

Expected dividends,

●

Expected volatility,

●

Risk-free interest rate; and

●

Expected life of option

Warrants

Basic and Diluted Earnings (Loss) per Share

At March 31, 2024 and 2023, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity securities:

Potentially dilutive equity securities

	March 31, 2024		December 31, 2023

Convertible Preferred Stock		700,000,000		700,000,000
Warrant		2,604,667		—

Each share of preferred stock (7,000,000 shares) is convertible into 100 shares of common stock.

New Accounting Standard Adopted

This guidance was adopted on January 1, 2024. The adoption of ASU 2022-03 did not have a material impact on the Company's consolidated financial statements.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Notes Payable and Convertible Notes Payable

3 Months Ended

Mar. 31, 2024

Notes Payable And Convertible Notes Payable

Notes Payable and Convertible Notes Payable

Note 3 – Notes Payable and Convertible Notes Payable

Notes Payable - Net

Notes payable are summarized as follows:

Summary of notes payable

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
June 2012	July 2024	8%	Unsecured	$	6,240	$	6,240
May 2014	July 2024	8%	Unsecured		3,456		3,456
June 2016	July 2024	8%	Unsecured		38,216		38,216
January 2017	July 2024	8%	Unsecured		7,344		7,344
November 2020	July 2024	12%	Unsecured		46,480		46,480
March 2021	July 2024	8%	Unsecured		5,400		5,400
November 2021	July 2024	0%	Unsecured		250,000		250,000
February 2022	July 2024	0%	Unsecured		150,000		150,000
August 2023	August 2024	8%	Unsecured		122,873		122,873
January 2023 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
October 2022 ⁽¹⁾	July 2024	0%	Unsecured		440,000		440,000
November 2022 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
			Notes payable	$	1,270,009	$	1,270,009

(1)	In November 2023, the convertible notes were amended to remove the conversion features and the Company reclassified $640,000 from convertible notes to notes payable.

Convertible Notes Payable - Net

The Company had the following activity related to its convertible notes payable:

Convertible notes payable, net


Balance - December 31, 2023	$	100,000
Proceeds (face amount of note)		300,000
Guaranteed Interest recorded to convertible note payable		5,000
Original issue debt discount		(10,000	)
Guaranteed interest – debt discount		(5,000	)
Amortization of debt discount		8,000
Balance – March 31, 2024	$	398,000

Convertible Notes Payable are summarized as follows:

Summary Of Convertible Notes Payable

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
October 2023	October 2024	8%	Unsecured	$	100,000		100,000
February 2024	May 2024	10%	Unsecured		55,000		-
March 2024	March 2025	8%	Unsecured		150,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
				$	405,000	$	100,000
			Less: unamortized debt discount		(7,000)		-
			Convertible notes payable – net		398,000	$	100,000

Notes Issued in 2024

Inducements

XML 20 R10.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 4 – Commitments and Contingencies

Schedule of monthly payment

Funds Raised	Paid Monthly	Accrued Monthly
$0 – $250,000	$3,750	$5,000
$250,000 – $750,000	$5,000	$3,750

Upon the Company’s raising of $750,000, it shall pay the accrued amount in cash. Thereafter, the Company

shall pay the entire monthly payment without accrual.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Stockholders’ Deficit

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Stockholders’ Deficit

Note 5 – Stockholders’ Deficit

The Company has two (2) classes of stock:

Common Stock

●

1,250,000,000 shares authorized

●

$0.001 par value

●

Voting at 1 vote per share

Preferred Stock

The Board of Directors has made the following designations of its preferred stock.

Series A, Convertible Preferred Stock

●

7,000,000 shares authorized.

●

$0.001 par value.

●

Conversion feature–-each share of preferred stock is convertible into 100 shares of common stock.

●

Voting–-on an as converted basis with common stock, at the applicable conversion rate (100 votes for each share of convertible preferred held).

●

Dividends–-accrued only upon declaration of the board of directors, at the applicable conversion rate.

●

Mandatorily redeemable (automatic conversion) on January 1, 2025. (See below amendment)

●

At March 31, 2024 and December 31, 2023, the Company had 7,000,000 shares issued and outstanding. See below for related issuances.

Equity Transactions for fiscal year 2024

During the three months ended March 31, 2024, the Company recorded 3,555,000 shares of common stock issuable as follows:

●

Securities Purchase Agreement

The Company agreed with the Investor that it will not enter into any other equity line or similar agreements without the prior consent of the Investor.

The Company has not sold any shares to the Investor as of March 31, 2024.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details

XML 22 R12.htm IDEA: XBRL DOCUMENT

Warrants

3 Months Ended

Mar. 31, 2024

Warrants

Warrants

Note 6 – Warrants

A summary of activity of the warrants during the three months ended March 31, 2024, is follows:

Summary of activity of the warrants

	Number of		Weighted average	Weighted average
	Warrant		Exercise price	Remaining life (year)
Outstanding at December 31, 2023	-	$	-	-
Grant	2,604,667		0.19	5.00
Exercised	-		-	-
Cancelled	-		-	-
Outstanding at March 31, 2024	2,604,667	$	0.19	4.87

The intrinsic value of the warrants as of March 31, 2024, is $148,545. All of the outstanding warrants are exercisable as of March 31, 2024.

Valuation

The Company utilizes the Black-Scholes model to value its warrants. The Company utilized the following assumptions:

Valuation assumptions


	Three months ended
	March 31, 2024
Expected term		5 years
Expected average volatility		338	%
Expected dividend yield		—
Risk-free interest rate		4.13	%

XML 23 R13.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events

Subsequent Events

Note 7 – Subsequent Events

On April 1, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated April 1, 2024, in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on April 1,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.

On May 9, 2024, the Company paid the $50,000 OID Note entered into in February, 2024 together with $5,000 in guaranteed interest and retired the Note.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Principles of Consolidation

Principles of Consolidation

Use of Estimates

Use of Estimates

Significant estimates during the three months ended March 31, 2024 and 2023 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The three tiers are defined as follows:

●

Level 1–- Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

●

Level 2–- Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

●

Level 3–-Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

Cash and Cash Equivalents and Concentration of Credit Risk

Cash and Cash Equivalents and Concentration of Credit Risk

At March 31, 2024 and December 31, 2023, respectively, the Company did not have any cash equivalents.

Revenue recognition

Revenue recognition

identify the contract with a customer;

identify the performance obligations in the contract;

determine the transaction price;

allocate the transaction price to performance obligations in the contract; and

recognize revenue as the performance obligation is satisfied.

Research and Development

Research and Development

The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”).

The Company incurred research and development expenses of $42,982 and $410,016 for the three months ended March 31, 2024 and 2023, respectively.

Advertising Costs

Advertising Costs

Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations.

The Company recognized $10,451 and $69,856 in marketing and advertising costs during the three months ended March 31, 2024 and 2023, respectively.

Stock-Based Compensation

Stock-Based Compensation

The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options and common stock warrant.

When determining fair value, the Company considers the following assumptions in the Black-Scholes model:

●

Exercise price,

●

Expected dividends,

●

Expected volatility,

●

Risk-free interest rate; and

●

Expected life of option

Warrants

Warrants

Basic and Diluted Earnings (Loss) per Share

Basic and Diluted Earnings (Loss) per Share

At March 31, 2024 and 2023, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity securities:

Potentially dilutive equity securities

	March 31, 2024		December 31, 2023

Convertible Preferred Stock		700,000,000		700,000,000
Warrant		2,604,667		—

Each share of preferred stock (7,000,000 shares) is convertible into 100 shares of common stock.

New Accounting Standard Adopted

New Accounting Standard Adopted

This guidance was adopted on January 1, 2024. The adoption of ASU 2022-03 did not have a material impact on the Company's consolidated financial statements.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Potentially dilutive equity securities

	March 31, 2024		December 31, 2023

Convertible Preferred Stock		700,000,000		700,000,000
Warrant		2,604,667		—

XML 26 R16.htm IDEA: XBRL DOCUMENT

Notes Payable and Convertible Notes Payable (Tables)

3 Months Ended

Mar. 31, 2024

Notes Payable And Convertible Notes Payable

Summary of notes payable

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
June 2012	July 2024	8%	Unsecured	$	6,240	$	6,240
May 2014	July 2024	8%	Unsecured		3,456		3,456
June 2016	July 2024	8%	Unsecured		38,216		38,216
January 2017	July 2024	8%	Unsecured		7,344		7,344
November 2020	July 2024	12%	Unsecured		46,480		46,480
March 2021	July 2024	8%	Unsecured		5,400		5,400
November 2021	July 2024	0%	Unsecured		250,000		250,000
February 2022	July 2024	0%	Unsecured		150,000		150,000
August 2023	August 2024	8%	Unsecured		122,873		122,873
January 2023 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
October 2022 ⁽¹⁾	July 2024	0%	Unsecured		440,000		440,000
November 2022 ⁽¹⁾	July 2024	0%	Unsecured		100,000		100,000
			Notes payable	$	1,270,009	$	1,270,009

Convertible notes payable, net


Balance - December 31, 2023	$	100,000
Proceeds (face amount of note)		300,000
Guaranteed Interest recorded to convertible note payable		5,000
Original issue debt discount		(10,000	)
Guaranteed interest – debt discount		(5,000	)
Amortization of debt discount		8,000
Balance – March 31, 2024	$	398,000

Summary Of Convertible Notes Payable

	Maturity	Interest		March 31,		December 31,
Issue Date	Date	Rate	Collateral	2024		2023
October 2023	October 2024	8%	Unsecured	$	100,000		100,000
February 2024	May 2024	10%	Unsecured		55,000		-
March 2024	March 2025	8%	Unsecured		150,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
March 2024	March 2025	8%	Unsecured		50,000		-
				$	405,000	$	100,000
			Less: unamortized debt discount		(7,000)		-
			Convertible notes payable – net		398,000	$	100,000

XML 27 R17.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of monthly payment

Funds Raised	Paid Monthly	Accrued Monthly
$0 – $250,000	$3,750	$5,000
$250,000 – $750,000	$5,000	$3,750

XML 28 R18.htm IDEA: XBRL DOCUMENT

Warrants (Tables)

3 Months Ended

Mar. 31, 2024

Warrants

Summary of activity of the warrants

	Number of		Weighted average	Weighted average
	Warrant		Exercise price	Remaining life (year)
Outstanding at December 31, 2023	-	$	-	-
Grant	2,604,667		0.19	5.00
Exercised	-		-	-
Cancelled	-		-	-
Outstanding at March 31, 2024	2,604,667	$	0.19	4.87

Valuation assumptions


	Three months ended
	March 31, 2024
Expected term		5 years
Expected average volatility		338	%
Expected dividend yield		—
Risk-free interest rate		4.13	%

XML 29 R19.htm IDEA: XBRL DOCUMENT

Organization and Nature of Operations (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net Loss	$ 1,610,880
Net cash used in operations	$ 102,865
Accumulated deficit		$ 5,853,362
Working capital deficit		1,647,565
Cash		$ 345,470	$ 108,335

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References + Details

XML 30 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Convertible Preferred Stock	$ 700,000,000	$ 700,000,000
Grant	2,604,667

XML 31 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Cash balance	$ 45,000	$ 0
Advertising costs	$ 10,451	$ 69,856

XML 32 R22.htm IDEA: XBRL DOCUMENT

Notes Payable and Convertible Notes Payable (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Notes Payable	$ 1,270,009	$ 1,270,009
Note Payable One [Member]
Short-Term Debt [Line Items]
Issue date	June 2012
Maturity Date	July 2024
Interest rate	8.00%
Collateral Description	Unsecured
Notes Payable	$ 6,240	6,240
Note Payable Two [Member]
Short-Term Debt [Line Items]
Issue date	May 2014
Maturity Date	July 2024
Interest rate	8.00%
Collateral Description	Unsecured
Notes Payable	$ 3,456	3,456
Note Payable Three [Member]
Short-Term Debt [Line Items]
Issue date	June 2016
Maturity Date	July 2024
Interest rate	8.00%
Collateral Description	Unsecured
Notes Payable	$ 38,216	38,216
Note Payable Four [Member]
Short-Term Debt [Line Items]
Issue date	January 2017
Maturity Date	July 2024
Interest rate	8.00%
Collateral Description	Unsecured
Notes Payable	$ 7,344	7,344
Note Payable Five [Member]
Short-Term Debt [Line Items]
Issue date	November 2020
Maturity Date	July 2024
Interest rate	12.00%
Collateral Description	Unsecured
Notes Payable	$ 46,480	46,480
Note Payable Six [Member]
Short-Term Debt [Line Items]
Issue date	March 2021
Maturity Date	July 2024
Interest rate	8.00%
Collateral Description	Unsecured
Notes Payable	$ 5,400	5,400
Note Payable Seven [Member]
Short-Term Debt [Line Items]
Issue date	November 2021
Maturity Date	July 2024
Interest rate	0.00%
Collateral Description	Unsecured
Notes Payable	$ 250,000	250,000
Note Payable Eight [Member]
Short-Term Debt [Line Items]
Issue date	February 2022
Maturity Date	July 2024
Interest rate	0.00%
Collateral Description	Unsecured
Notes Payable	$ 150,000	150,000
Note Payable Nine [Member]
Short-Term Debt [Line Items]
Issue date	August 2023
Maturity Date	August 2024
Interest rate	8.00%
Collateral Description	Unsecured
Notes Payable	$ 122,873	122,873
Note Payable Ten [Member]
Short-Term Debt [Line Items]
Issue date	January 2023 (1)
Maturity Date	July 2024
Interest rate	0.00%
Collateral Description	Unsecured
Notes Payable	$ 100,000	100,000
Note Payable Eleven [Member]
Short-Term Debt [Line Items]
Issue date	October 2022 (1)
Maturity Date	July 2024
Interest rate	0.00%
Collateral Description	Unsecured
Notes Payable	$ 440,000	440,000
Note Payable Twelve [Member]
Short-Term Debt [Line Items]
Issue date	November 2022 (1)
Maturity Date	July 2024
Interest rate	0.00%
Notes Payable	$ 100,000	$ 100,000

XML 33 R23.htm IDEA: XBRL DOCUMENT

Notes Payable and Convertible Notes Payable (Details 1)	3 Months Ended
Notes Payable and Convertible Notes Payable (Details 1)	Mar. 31, 2024 USD ($)
Notes Payable And Convertible Notes Payable
Balance - December 31, 2023	$ 100,000
Proceeds (face amount of note)	300,000
Guaranteed Interest recorded to convertible note payable	5,000
Original issue debt discount	(10,000)
[custom:GuaranteedInterestDebtDscount]	(5,000)
Accretion of debt discount recorded to interest expense	8,000
Convertible Notes Payable	$ 398,000

XML 34 R24.htm IDEA: XBRL DOCUMENT

Notes Payable and Convertible Notes Payable (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Long-Term Debt	$ 405,000	$ 100,000
Unamortized debt discount	(7,000)
[custom:ConvertibleNotesPayableNet-0]	$ 398,000	100,000
Convertible Notes Payable One [Member]
Short-Term Debt [Line Items]
issue date	October 2023
Maturity Date	October 2024
Interest rate	8.00%
Collateral description	Unsecured
Convertible Notes Payable, Noncurrent	$ 100,000	100,000
Convertible Notes Payable Two [Member]
Short-Term Debt [Line Items]
issue date	February 2024
Maturity Date	May 2024
Interest rate	10.00%
Collateral description	Unsecured
Convertible Notes Payable, Noncurrent	$ 55,000
Convertible Notes Payable Three [Member]
Short-Term Debt [Line Items]
issue date	March 2024
Maturity Date	March 2025
Interest rate	8.00%
Collateral description	Unsecured
Convertible Notes Payable, Noncurrent	$ 150,000
Convertible Notes Payable Four [Member]
Short-Term Debt [Line Items]
issue date	March 2024
Maturity Date	March 2025
Interest rate	8.00%
Collateral description	Unsecured
Convertible Notes Payable, Noncurrent	$ 50,000
Convertible Notes Payable Five [Member]
Short-Term Debt [Line Items]
issue date	March 2024
Convertible Notes Payable Fiver [Member]
Short-Term Debt [Line Items]
Maturity Date	March 2025
Interest rate	8.00%
Collateral description	Unsecured
Convertible Notes Payable, Noncurrent	$ 50,000

XML 35 R25.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details)	3 Months Ended
Commitments and Contingencies (Details)	Mar. 31, 2024 USD ($)
Loss Contingencies [Line Items]
Monthly payment	$ 3,750
Accrued Monthly	5,000
Second Monthly payment	5,000
Second Accrued Monthly	3,750
Minimum [Member]
Loss Contingencies [Line Items]
Fund raised	0
Fund raised second range	250,000
Maximum [Member]
Loss Contingencies [Line Items]
Fund raised	250,000
Fund raised second range	$ 750,000

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

XML 36 R26.htm IDEA: XBRL DOCUMENT

Warrants (Details) - USD ($)	3 Months Ended	12 Months Ended
Warrants (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Warrants
Outstanding at December 31, 2023	$ (0)
Outstanding at December 31, 2023	$ (0)
Outstanding at December 31, 2023
Grant	2,604,667
Grant	$ 0.19
Grant	5 years
Outstanding at March 31, 2024	$ 2,604,667	$ (0)
Outstanding at March 31, 2024	$ 0.19	$ (0)
Outstanding at March 31, 2024	4 years 10 months 13 days

XML 37 R27.htm IDEA: XBRL DOCUMENT

Warrants (Details 1)	3 Months Ended
Warrants (Details 1)	Mar. 31, 2024
Warrants
Expected term	5 years
Expected average volatility	338.00%
Expected dividend yield	0.00%
Risk-free interest rate	4.13%

EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 39 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 90 155 1 false 25 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://ludwigent.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://ludwigent.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://ludwigent.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://ludwigent.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Stockholders Deficit (Unaudited) Sheet http://ludwigent.com/role/StatementsOfStockholdersDeficit Statements of Stockholders Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statement of Cashflows Sheet http://ludwigent.com/role/StatementOfCashflows Consolidated Statement of Cashflows Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Nature of Operations Sheet http://ludwigent.com/role/OrganizationAndNatureOfOperations Organization and Nature of Operations Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://ludwigent.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Notes Payable and Convertible Notes Payable Notes http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayable Notes Payable and Convertible Notes Payable Notes 9 false false R10.htm 00000010 - Disclosure - Commitments and Contingencies Sheet http://ludwigent.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 10 false false R11.htm 00000011 - Disclosure - Stockholders??? Deficit Sheet http://ludwigent.com/role/StockholdersDeficit Stockholders??? Deficit Notes 11 false false R12.htm 00000012 - Disclosure - Warrants Sheet http://ludwigent.com/role/Warrants Warrants Notes 12 false false R13.htm 00000013 - Disclosure - Subsequent Events Sheet http://ludwigent.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://ludwigent.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://ludwigent.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Notes Payable and Convertible Notes Payable (Tables) Notes http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables Notes Payable and Convertible Notes Payable (Tables) Tables http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayable 16 false false R17.htm 00000017 - Disclosure - Commitments and Contingencies (Tables) Sheet http://ludwigent.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://ludwigent.com/role/CommitmentsAndContingencies 17 false false R18.htm 00000018 - Disclosure - Warrants (Tables) Sheet http://ludwigent.com/role/WarrantsTables Warrants (Tables) Tables http://ludwigent.com/role/Warrants 18 false false R19.htm 00000019 - Disclosure - Organization and Nature of Operations (Details Narrative) Sheet http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative Organization and Nature of Operations (Details Narrative) Details http://ludwigent.com/role/OrganizationAndNatureOfOperations 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 00000022 - Disclosure - Notes Payable and Convertible Notes Payable (Details) Notes http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails Notes Payable and Convertible Notes Payable (Details) Details http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables 22 false false R23.htm 00000023 - Disclosure - Notes Payable and Convertible Notes Payable (Details 1) Notes http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1 Notes Payable and Convertible Notes Payable (Details 1) Details http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables 23 false false R24.htm 00000024 - Disclosure - Notes Payable and Convertible Notes Payable (Details 2) Notes http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2 Notes Payable and Convertible Notes Payable (Details 2) Details http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables 24 false false R25.htm 00000025 - Disclosure - Commitments and Contingencies (Details) Sheet http://ludwigent.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://ludwigent.com/role/CommitmentsAndContingenciesTables 25 false false R26.htm 00000026 - Disclosure - Warrants (Details) Sheet http://ludwigent.com/role/WarrantsDetails Warrants (Details) Details http://ludwigent.com/role/WarrantsTables 26 false false R27.htm 00000027 - Disclosure - Warrants (Details 1) Sheet http://ludwigent.com/role/WarrantsDetails1 Warrants (Details 1) Details http://ludwigent.com/role/WarrantsTables 27 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentTransitionReport, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 - ludg_10q.htm 28, 74 [dqc-0015-Negative-Values] Fact us-gaap:DebtInstrumentUnamortizedDiscount has a value of -7000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:DebtInstrumentUnamortizedDiscount fact are: Context: AsOf2024-03-31, Unit: USD, Rule Element Id: 7193. ludg_10q.htm 3031 [DQC.US.0043.9873] The company has reported the concept ProfitLoss as part of the cash flow statement. This income item is being deducted from the value of operating cash flows in the calculation defined by the filer. This implies that the resulting operating cash flow calculation excludes this income item from cash flow from operations. If ProfitLoss represents income from discontinued operations then the element NetCashProvidedByUsedInOperatingActivitiesContinuingOperations should be used as the total rather than the current total element of NetCashProvidedByUsedInOperatingActivities. If the item is an income item and is being deducted because the value is negative then consider changing the sign and weight of the element. - https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd 4812, 9402 - https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd 4812, 9402 [DQC.US.0099.9533] The following elements are in the presentation linkbase of http://ludwigent.com/role/StatementsOfOperations but are not included in any calculation relationship in the filing. IncomeTaxExpenseBenefit, OtherNonoperatingExpense All elements appearing in the face of the financial statements should be included in a calculation relationship somewhere in the filing. Items not included in the financial statement calculations but included in the presentation are referred to as parenthetical items. These usually appear as a referenced item, or as a value in parenthesis describing that the value reported includes another specific amount. These values should be reported in a seperate link role for parenthetical items. This rule will produce an error irrespective of a fact value being entered for the item(s) listed above. If the item is an additional disclosure in the income statement statement then make sure that is included as a child of one of the following abstract items: ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract, SupplementalIncomeStatementElementsAbstract - ludg_10q.htm - ludg_10q.htm [DQC.US.0099.9533] The following elements are in the presentation linkbase of http://ludwigent.com/role/StatementOfCashflows but are not included in any calculation relationship in the filing. OriginalIssuanceDebtDiscount All elements appearing in the face of the financial statements should be included in a calculation relationship somewhere in the filing. Items not included in the financial statement calculations but included in the presentation are referred to as parenthetical items. These usually appear as a referenced item, or as a value in parenthesis describing that the value reported includes another specific amount. These values should be reported in a seperate link role for parenthetical items. This rule will produce an error irrespective of a fact value being entered for the item(s) listed above. If the item is an additional disclosure in the cash flow statement then make sure that is included as a child of one of the following abstract items: {nonCFabstracts} - ludg_10q.htm - ludg_10q.htm ludg-20240513.xsd ludg-20240513_cal.xml ludg-20240513_def.xml ludg-20240513_lab.xml ludg-20240513_pre.xml ludg_10q.htm http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 true true JSON 45 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ludg_10q.htm": { "nsprefix": "LUDG", "nsuri": "http://ludwigent.com/20240513", "dts": { "schema": { "local": [ "ludg-20240513.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "ludg-20240513_cal.xml" ] }, "definitionLink": { "local": [ "ludg-20240513_def.xml" ] }, "labelLink": { "local": [ "ludg-20240513_lab.xml" ] }, "presentationLink": { "local": [ "ludg-20240513_pre.xml" ] }, "inline": { "local": [ "ludg_10q.htm" ] } }, "keyStandard": 118, "keyCustom": 37, "axisStandard": 4, "axisCustom": 0, "memberStandard": 6, "memberCustom": 19, "hidden": { "total": 52, "http://fasb.org/us-gaap/2024": 38, "http://ludwigent.com/20240513": 8, "http://xbrl.sec.gov/dei/2024": 6 }, "contextCount": 90, "entityCount": 1, "segmentCount": 25, "elementCount": 246, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 259, "http://xbrl.sec.gov/dei/2024": 27 }, "report": { "R1": { "role": "http://ludwigent.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://ludwigent.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets (Unaudited)", "shortName": "Consolidated Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "unique": true } }, "R3": { "role": "http://ludwigent.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R4": { "role": "http://ludwigent.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations (Unaudited)", "shortName": "Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://ludwigent.com/role/StatementsOfStockholdersDeficit", "longName": "00000005 - Statement - Statements of Stockholders Deficit (Unaudited)", "shortName": "Statements of Stockholders Deficit (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_ConvertiblePreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_ConvertiblePreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://ludwigent.com/role/StatementOfCashflows", "longName": "00000006 - Statement - Consolidated Statement of Cashflows", "shortName": "Consolidated Statement of Cashflows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R7": { "role": "http://ludwigent.com/role/OrganizationAndNatureOfOperations", "longName": "00000007 - Disclosure - Organization and Nature of Operations", "shortName": "Organization and Nature of Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://ludwigent.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayable", "longName": "00000009 - Disclosure - Notes Payable and Convertible Notes Payable", "shortName": "Notes Payable and Convertible Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://ludwigent.com/role/CommitmentsAndContingencies", "longName": "00000010 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://ludwigent.com/role/StockholdersDeficit", "longName": "00000011 - Disclosure - Stockholders\u2019 Deficit", "shortName": "Stockholders\u2019 Deficit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://ludwigent.com/role/Warrants", "longName": "00000012 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://ludwigent.com/role/SubsequentEvents", "longName": "00000013 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000014 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000015 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables", "longName": "00000016 - Disclosure - Notes Payable and Convertible Notes Payable (Tables)", "shortName": "Notes Payable and Convertible Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://ludwigent.com/role/CommitmentsAndContingenciesTables", "longName": "00000017 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:ScheduleOfMonthlyPaymentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:ScheduleOfMonthlyPaymentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://ludwigent.com/role/WarrantsTables", "longName": "00000018 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "LUDG:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "LUDG:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative", "longName": "00000019 - Disclosure - Organization and Nature of Operations (Details Narrative)", "shortName": "Organization and Nature of Operations (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "LUDG:NetLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "LUDG:NetLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetails", "longName": "00000020 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000021 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "longName": "00000022 - Disclosure - Notes Payable and Convertible Notes Payable (Details)", "shortName": "Notes Payable and Convertible Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OtherNotesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OtherNotesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1", "longName": "00000023 - Disclosure - Notes Payable and Convertible Notes Payable (Details 1)", "shortName": "Notes Payable and Convertible Notes Payable (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "LUDG:ConvertibleNotesPayableNetTableTextBlock", "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "LUDG:ConvertibleNotesPayableNetTableTextBlock", "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2", "longName": "00000024 - Disclosure - Notes Payable and Convertible Notes Payable (Details 2)", "shortName": "Notes Payable and Convertible Notes Payable (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "LUDG:SummaryOfConvertibleNotesPayableTableTextBlock", "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LongTermDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "LUDG:SummaryOfConvertibleNotesPayableTableTextBlock", "LUDG:NotesPayableAndConvertibleNotesPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://ludwigent.com/role/CommitmentsAndContingenciesDetails", "longName": "00000025 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:MonthlyPayment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "LUDG:ScheduleOfMonthlyPaymentTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "LUDG:MonthlyPayment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "LUDG:ScheduleOfMonthlyPaymentTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://ludwigent.com/role/WarrantsDetails", "longName": "00000026 - Disclosure - Warrants (Details)", "shortName": "Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:WarrantsAndRightsOutstanding", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "LUDG:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "LUDG:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "unique": true } }, "R27": { "role": "http://ludwigent.com/role/WarrantsDetails1", "longName": "00000027 - Disclosure - Warrants (Details 1)", "shortName": "Warrants (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "LUDG:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "LUDG:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ludg_10q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndOtherAccruedLiabilities", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other." } } }, "auth_ref": [ "r310" ] }, "LUDG_AccretionOfDebtDiscountRecordedToInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "AccretionOfDebtDiscountRecordedToInterestExpense", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Accretion of debt discount recorded to interest expense" } } }, "auth_ref": [] }, "LUDG_AccruedMonthly": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "AccruedMonthly", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Monthly" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r37", "r400", "r489" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r294", "r442", "r443", "r444", "r445", "r470", "r490" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "LUDG_Advance": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "Advance", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Cash advance from investor" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r73" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising costs", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r215", "r391" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Amortization of debt discount", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r3", "r45", "r179", "r477" ] }, "LUDG_AmortizationOfDebtDiscountPremiumOne": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "AmortizationOfDebtDiscountPremiumOne", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "verboseLabel": "Amortization of debt discount", "label": "AmortizationOfDebtDiscountPremiumOne" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r427" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r60", "r70", "r85", "r102", "r123", "r127", "r134", "r135", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r230", "r234", "r246", "r265", "r330", "r380", "r381", "r400", "r412", "r464", "r465", "r479" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r83", "r90", "r102", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r230", "r234", "r246", "r400", "r464", "r465", "r479" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r427" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Cash", "crdr": "debit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets", "http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r72", "r266", "r305", "r325", "r400", "r412", "r435" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents and Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r11" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, beginning of period", "periodEndLabel": "Cash, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r9", "r48", "r99" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r48" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash balance", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash financing activity" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r79", "r86", "r87", "r88", "r102", "r117", "r118", "r120", "r121", "r125", "r126", "r140", "r155", "r157", "r158", "r159", "r162", "r163", "r182", "r183", "r185", "r188", "r194", "r246", "r287", "r288", "r289", "r290", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r306", "r317", "r339", "r356", "r366", "r367", "r368", "r369", "r370", "r433", "r439", "r446" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at December 31, 2023", "periodEndLabel": "Outstanding at March 31, 2024", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r195" ] }, "LUDG_CollateralDescription": { "xbrltype": "stringItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "CollateralDescription", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Collateral Description", "verboseLabel": "Collateral description" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r54", "r146", "r147", "r373", "r456", "r461" ] }, "LUDG_CommonStockIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "CommonStockIssuable", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock issuable" } } }, "auth_ref": [] }, "LUDG_CommonStockIssuableMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "CommonStockIssuableMember", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock Issuable [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r402", "r403", "r404", "r406", "r407", "r408", "r409", "r442", "r443", "r445", "r470", "r488", "r490" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r35" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r35", "r317" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Commons stock, issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r35" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Commons stock, outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r4", "r35", "r317", "r336", "r490", "r491" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock: 1,250,000,000 authorized; $0.001 par value, 155,464,808 and 155,464,808 shares issued and outstanding, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r35", "r268", "r400" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r23", "r377" ] }, "us-gaap_ConvertibleLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleLongTermNotesPayable", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable, Noncurrent", "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance - December 31, 2023", "periodEndLabel": "Convertible Notes Payable", "label": "Convertible Notes Payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r7", "r62", "r487" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible notes payable, net", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r27" ] }, "LUDG_ConvertibleNotesPayableFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableFiveMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Five [Member]" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableFiverMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableFiverMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Fiver [Member]" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableFourMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableFourMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Four [Member]" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableNet", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "[custom:ConvertibleNotesPayableNet-0]" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableNetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableNetTableTextBlock", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Convertible notes payable, net", "label": "ConvertibleNotesPayableNetTableTextBlock" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableOneMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable One [Member]" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableThreeMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Three [Member]" } } }, "auth_ref": [] }, "LUDG_ConvertibleNotesPayableTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ConvertibleNotesPayableTwoMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Two [Member]" } } }, "auth_ref": [] }, "us-gaap_ConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertiblePreferredStockMember", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Convertible Preferred Stock [Member]", "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option." } } }, "auth_ref": [ "r182", "r183", "r185", "r406", "r407", "r408", "r409" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerAdvancesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerAdvancesCurrent", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Advances", "documentation": "The current portion of prepayments received from customers for goods or services to be provided in the future." } } }, "auth_ref": [ "r66" ] }, "LUDG_DebtDiscountBeneficialConversionFeatureNote": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "DebtDiscountBeneficialConversionFeatureNote", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Original issue debt discount" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r7", "r26", "r27", "r61", "r62", "r103", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r384", "r385", "r386", "r387", "r388", "r399", "r440", "r457", "r458", "r459", "r476", "r478" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Interest rate", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r29", "r176", "r476" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r7", "r103", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r384", "r385", "r386", "r387", "r388", "r399", "r440", "r457", "r458", "r459", "r476", "r478" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Unamortized debt discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r467", "r475", "r476", "r478" ] }, "LUDG_DisclosureNotesPayableAndConvertibleNotesPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "DisclosureNotesPayableAndConvertibleNotesPayableAbstract", "lang": { "en-us": { "role": { "label": "Notes Payable And Convertible Notes Payable" } } }, "auth_ref": [] }, "LUDG_DisclosureSubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "DisclosureSubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "auth_ref": [] }, "LUDG_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r426" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r424", "r426", "r427" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r425" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r413" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r426" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r426" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r428" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r416" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basic and Diluted Earnings (Loss) per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r13", "r14", "r122" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r419" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r415" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r415" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r432" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r415" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r429" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r427" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r415" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r415" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r415" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r415" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r430" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r4", "r80", "r93", "r94", "r95", "r104", "r105", "r106", "r108", "r113", "r114", "r116", "r124", "r141", "r142", "r145", "r196", "r219", "r220", "r222", "r223", "r224", "r226", "r227", "r228", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r247", "r248", "r249", "r250", "r251", "r252", "r254", "r256", "r257", "r274", "r278", "r279", "r280", "r294", "r356" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Potentially dilutive equity securities", "documentation": "Tabular disclosure of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r452", "r453", "r454" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "LUDG_FundRaised": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "FundRaised", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Fund raised" } } }, "auth_ref": [] }, "LUDG_FundRaisedSecond": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "FundRaisedSecond", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Fund raised second range" } } }, "auth_ref": [] }, "LUDG_GeneralAndAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "GeneralAndAdministrativeExpenses", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administration expenses" } } }, "auth_ref": [] }, "LUDG_GuaranteedInterestDebtDscount": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "GuaranteedInterestDebtDscount", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1" ], "lang": { "en-us": { "role": { "label": "[custom:GuaranteedInterestDebtDscount]" } } }, "auth_ref": [] }, "LUDG_GuaranteedInterestRecordedToConvertibleNotePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "GuaranteedInterestRecordedToConvertibleNotePayable", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Guaranteed Interest recorded to convertible note payable" } } }, "auth_ref": [] }, "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]", "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities." } } }, "auth_ref": [ "r153" ] }, "us-gaap_IncomeLossAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossAttributableToParent", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss from operations", "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments." } } }, "auth_ref": [ "r44", "r95" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income tax benefit", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r71", "r78", "r115", "r116", "r123", "r131", "r135", "r217", "r218", "r221", "r275", "r392" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Cash paid for taxes", "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r12", "r50", "r438", "r468", "r469" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDeposits", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Deposit", "documentation": "The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances." } } }, "auth_ref": [ "r10", "r65" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "LUDG_InducementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "InducementExpense", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "verboseLabel": "Inducement expense", "label": "InducementExpense" } } }, "auth_ref": [] }, "LUDG_InducementExpenseOne": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "InducementExpenseOne", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Inducement expense" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OtherNoncashIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense, Operating and Nonoperating", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r123", "r127", "r130", "r132", "r135", "r253", "r380", "r381" ] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r437" ] }, "LUDG_IssueDateDescrption": { "xbrltype": "stringItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "IssueDateDescrption", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Issue date", "verboseLabel": "issue date" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Total Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r7", "r26", "r27", "r28", "r30", "r31", "r32", "r33", "r102", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r231", "r234", "r235", "r246", "r316", "r378", "r412", "r464", "r479", "r480" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders' Deficit", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r42", "r63", "r271", "r400", "r441", "r455", "r474" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Deficit" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r28", "r84", "r102", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r231", "r234", "r235", "r246", "r400", "r464", "r479", "r480" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r7", "r62", "r171", "r180", "r385", "r386", "r399", "r487" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r148", "r149", "r150", "r154", "r214", "r383", "r462", "r463" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r148", "r149", "r150", "r154", "r214", "r383", "r462", "r463" ] }, "LUDG_LossPerShareBasicAndDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "LossPerShareBasicAndDiluted", "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic and diluted loss per common share" } } }, "auth_ref": [] }, "LUDG_MaturityDate": { "xbrltype": "stringItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "MaturityDate", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Maturity Date" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r198", "r214", "r245", "r262", "r276", "r277", "r283", "r307", "r308", "r361", "r362", "r363", "r364", "r365", "r374", "r375", "r382", "r389", "r390", "r395", "r396", "r397", "r398", "r401", "r466", "r481", "r482", "r483", "r484", "r485", "r486" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r198", "r214", "r245", "r262", "r276", "r277", "r283", "r307", "r308", "r361", "r362", "r363", "r364", "r365", "r374", "r375", "r382", "r389", "r390", "r395", "r396", "r397", "r401", "r466", "r481", "r482", "r483", "r484", "r485", "r486" ] }, "LUDG_MonthlyPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "MonthlyPayment", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Monthly payment" } } }, "auth_ref": [] }, "LUDG_MonthlyPaymentSecond": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "MonthlyPaymentSecond", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Second Monthly payment" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Provided by Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r98" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Used in Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r48", "r49", "r51" ] }, "LUDG_NetCashUsedInOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NetCashUsedInOperations", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net cash used in operations" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations", "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r44", "r51", "r64", "r82", "r91", "r92", "r95", "r102", "r107", "r109", "r110", "r111", "r112", "r113", "r115", "r116", "r119", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r225", "r228", "r244", "r246", "r273", "r338", "r354", "r355", "r410", "r464" ] }, "LUDG_NetLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NetLoss", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net Loss" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "LUDG_NotePayableEightMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableEightMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Eight [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableElevenMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableElevenMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Eleven [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableFiveMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Five [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableFourMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableFourMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Four [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableNineMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableNineMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Nine [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableOneMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable One [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableSevenMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableSevenMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Seven [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableSixMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableSixMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Six [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableTenMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableTenMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Ten [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableThreeMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Three [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableTwelveMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableTwelveMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Twelve [Member]" } } }, "auth_ref": [] }, "LUDG_NotePayableTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotePayableTwoMember", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Note Payable Two [Member]" } } }, "auth_ref": [] }, "LUDG_NotesPayableAndConvertibleNotesPayableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "NotesPayableAndConvertibleNotesPayableTextBlock", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayable" ], "lang": { "en-us": { "role": { "label": "Notes Payable and Convertible Notes Payable" } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes payable", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r26", "r27" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r69", "r379", "r447", "r448", "r449", "r450", "r451" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://ludwigent.com/role/OrganizationAndNatureOfOperations" ], "lang": { "en-us": { "role": { "label": "Organization and Nature of Operations", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r25", "r59", "r284", "r285" ] }, "LUDG_OriginalIssuanceDebtDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "OriginalIssuanceDebtDiscount", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Original issuance debt and guaranteed interest as debt discount" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r51" ] }, "us-gaap_OtherNonoperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingExpense", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense)", "documentation": "Amount of expense related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r46" ] }, "us-gaap_OtherNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNotesPayableCurrent", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Notes Payable", "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r27" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r426" ] }, "us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfConvertiblePreferredStock", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Preferred Stock", "documentation": "The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury." } } }, "auth_ref": [ "r47" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r420" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r422" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r34", "r182" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r34", "r317" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r34", "r182" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://ludwigent.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r34", "r317", "r336", "r490", "r491" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r34", "r267", "r400" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r89", "r143", "r144", "r376" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Standard Adopted", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r434" ] }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Proceeds from convertible notes payable - net", "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Proceeds (face amount of note)", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r82", "r91", "r92", "r97", "r102", "r107", "r113", "r115", "r116", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r225", "r228", "r229", "r232", "r233", "r244", "r246", "r264", "r272", "r293", "r338", "r354", "r355", "r393", "r394", "r411", "r436", "r464" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r197", "r198", "r206", "r207", "r208", "r214", "r245", "r260", "r261", "r262", "r276", "r277", "r283", "r307", "r308", "r361", "r362", "r363", "r364", "r365", "r374", "r375", "r382", "r389", "r390", "r395", "r396", "r397", "r398", "r401", "r404", "r460", "r466", "r472", "r482", "r483", "r484", "r485", "r486" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "auth_ref": [ "r149", "r150", "r151", "r152", "r197", "r198", "r206", "r207", "r208", "r214", "r245", "r260", "r261", "r262", "r276", "r277", "r283", "r307", "r308", "r361", "r362", "r363", "r364", "r365", "r374", "r375", "r382", "r389", "r390", "r395", "r396", "r397", "r398", "r401", "r404", "r460", "r466", "r472", "r482", "r483", "r484", "r485", "r486" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r216" ] }, "LUDG_ResearchAndDevelopmentInExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ResearchAndDevelopmentInExpenses", "crdr": "debit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Research and development" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r39", "r56", "r270", "r281", "r282", "r291", "r318", "r400" ] }, "us-gaap_RetainedEarningsAppropriated": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAppropriated", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated deficit", "label": "Retained Earnings, Appropriated", "documentation": "Amount of accumulated undistributed earnings (deficit) not available for dividend distribution. Includes, but is not limited to, retained earnings appropriated for specific business purpose." } } }, "auth_ref": [ "r18", "r19", "r38", "r101", "r269" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r80", "r104", "r105", "r106", "r108", "r113", "r114", "r116", "r141", "r142", "r145", "r219", "r220", "r222", "r223", "r224", "r226", "r227", "r228", "r236", "r238", "r239", "r241", "r243", "r254", "r256", "r278", "r280", "r294", "r490" ] }, "us-gaap_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue recognition", "documentation": "Disclosure of accounting policy for recognizing revenue from a transaction on a gross or net basis." } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r67", "r68", "r96", "r102", "r123", "r128", "r129", "r133", "r135", "r136", "r137", "r138", "r140", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r246", "r264", "r380", "r464" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables" ], "lang": { "en-us": { "role": { "label": "Summary of notes payable", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r36", "r43" ] }, "LUDG_ScheduleOfMonthlyPaymentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "ScheduleOfMonthlyPaymentTableTextBlock", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of monthly payment" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://ludwigent.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Summary of activity of the warrants", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r5", "r6", "r57" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://ludwigent.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Valuation assumptions", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r58" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Table]", "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability." } } }, "auth_ref": [ "r26" ] }, "LUDG_SecondAccruedMonthly": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "SecondAccruedMonthly", "crdr": "debit", "presentation": [ "http://ludwigent.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Second Accrued Monthly" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r414" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r418" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r417" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r423" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://ludwigent.com/role/WarrantsDetails1" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r207" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://ludwigent.com/role/WarrantsDetails1" ], "lang": { "en-us": { "role": { "label": "Expected average volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r206" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://ludwigent.com/role/WarrantsDetails1" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r208" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Grant", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r201" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Grant", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r201" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r199", "r200", "r203", "r204", "r205", "r206", "r209", "r210", "r211", "r212", "r213" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://ludwigent.com/role/WarrantsDetails1" ], "lang": { "en-us": { "role": { "label": "Expected term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r205" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Outstanding at December 31, 2023", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r202" ] }, "LUDG_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Outstanding at March 31, 2024" } } }, "auth_ref": [] }, "LUDG_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3": { "xbrltype": "durationItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3", "presentation": [ "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Grant", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Beginning balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtLineItems", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails", "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableDetails2" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r52", "r100" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r421" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r79", "r86", "r87", "r88", "r102", "r117", "r118", "r120", "r121", "r125", "r126", "r140", "r155", "r157", "r158", "r159", "r162", "r163", "r182", "r183", "r185", "r188", "r194", "r246", "r287", "r288", "r289", "r290", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r306", "r317", "r339", "r356", "r366", "r367", "r368", "r369", "r370", "r433", "r439", "r446" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r4", "r35", "r40", "r41", "r80", "r93", "r94", "r95", "r104", "r105", "r106", "r108", "r113", "r114", "r116", "r124", "r141", "r142", "r145", "r196", "r219", "r220", "r222", "r223", "r224", "r226", "r227", "r228", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r247", "r248", "r249", "r250", "r251", "r252", "r254", "r256", "r257", "r274", "r278", "r279", "r280", "r294", "r356" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r104", "r105", "r106", "r124", "r256", "r263", "r286", "r306", "r309", "r311", "r312", "r313", "r314", "r315", "r317", "r320", "r321", "r322", "r323", "r324", "r326", "r327", "r328", "r329", "r331", "r332", "r333", "r334", "r335", "r337", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r356", "r405" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r104", "r105", "r106", "r124", "r139", "r256", "r263", "r286", "r306", "r309", "r311", "r312", "r313", "r314", "r315", "r317", "r320", "r321", "r322", "r323", "r324", "r326", "r327", "r328", "r329", "r331", "r332", "r333", "r334", "r335", "r337", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r356", "r405" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r4", "r20", "r35", "r40", "r56", "r174" ] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Beginning balance, shares", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "verboseLabel": "Beginning balance, shares", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r4", "r34", "r35", "r56", "r287", "r356", "r367" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issuable for note extension included in inducement expense", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r4", "r35", "r40", "r41", "r56" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock issued for services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock issued for license fee", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r4", "r34", "r35", "r56", "r294", "r356", "r367", "r411" ] }, "LUDG_StockIssuedForLicenseFee": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "StockIssuedForLicenseFee", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Stock warrants issued for finance cost" } } }, "auth_ref": [] }, "LUDG_StockIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "StockIssuedForServices", "crdr": "credit", "calculation": { "http://ludwigent.com/role/StatementOfCashflows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/StatementOfCashflows" ], "lang": { "en-us": { "role": { "label": "Stock issuable for services" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r35", "r40", "r41", "r53", "r319", "r336", "r357", "r358", "r400", "r412", "r441", "r455", "r474", "r490" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Deficit" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://ludwigent.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ludwigent.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders' Deficit", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r21", "r22", "r24", "r80", "r81", "r94", "r104", "r105", "r106", "r108", "r113", "r114", "r141", "r142", "r145", "r196", "r219", "r220", "r222", "r223", "r224", "r226", "r227", "r228", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r247", "r248", "r252", "r255", "r257", "r279", "r280", "r292", "r319", "r336", "r357", "r358", "r371", "r411", "r441", "r455", "r474", "r490" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://ludwigent.com/role/StockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r55", "r101", "r181", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r196", "r242", "r359", "r360", "r372" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://ludwigent.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "verboseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r258", "r259" ] }, "LUDG_SummaryOfConvertibleNotesPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "SummaryOfConvertibleNotesPayableTableTextBlock", "presentation": [ "http://ludwigent.com/role/NotesPayableAndConvertibleNotesPayableTables" ], "lang": { "en-us": { "role": { "label": "Summary Of Convertible Notes Payable" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://ludwigent.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r15", "r16", "r17", "r74", "r75", "r76", "r77" ] }, "LUDG_WarrantIssuedForCommitmentFee": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "WarrantIssuedForCommitmentFee", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/StatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Warrant issued for commitment fee" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at December 31, 2023", "periodEndLabel": "Outstanding at March 31, 2024", "label": "Warrants and Rights Outstanding", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [ "r471", "r472", "r473" ] }, "LUDG_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "WarrantsTextBlock", "presentation": [ "http://ludwigent.com/role/Warrants" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "label": "WarrantsTextBlock" } } }, "auth_ref": [] }, "LUDG_WeightedAverageNumberOfSharesBasicAndDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "WeightedAverageNumberOfSharesBasicAndDiluted", "presentation": [ "http://ludwigent.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, basic and diluted" } } }, "auth_ref": [] }, "LUDG_WorkingCapitalDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://ludwigent.com/20240513", "localname": "WorkingCapitalDeficit", "crdr": "credit", "presentation": [ "http://ludwigent.com/role/OrganizationAndNatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital deficit" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ludwigent.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r431" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-8" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-4" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479024/942-230-45-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/460/tableOfContent" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(10)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r378": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r379": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r380": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r381": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r382": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r383": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r384": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r385": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r386": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r387": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r388": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r389": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r390": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r391": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r393": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r413": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r414": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r415": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r417": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r419": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r420": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r424": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r425": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r426": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r427": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r428": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r430": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r431": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r432": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r433": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r475": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r476": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r477": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r478": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r479": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r480": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r481": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r482": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r483": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r484": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r485": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r486": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r487": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r489": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r491": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 46 0001903596-24-000339-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001903596-24-000339-xbrl.zip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ludg_10q_htm.xml IDEA: XBRL DOCUMENT 0001960262 2024-01-01 2024-03-31 0001960262 2024-05-20 0001960262 2024-03-31 0001960262 2023-12-31 0001960262 2023-01-01 2023-03-31 0001960262 us-gaap:ConvertiblePreferredStockMember 2023-12-31 0001960262 us-gaap:CommonStockMember 2023-12-31 0001960262 LUDG:CommonStockIssuableMember 2023-12-31 0001960262 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001960262 us-gaap:RetainedEarningsMember 2023-12-31 0001960262 us-gaap:ConvertiblePreferredStockMember 2022-12-31 0001960262 us-gaap:CommonStockMember 2022-12-31 0001960262 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001960262 us-gaap:RetainedEarningsMember 2022-12-31 0001960262 2022-12-31 0001960262 us-gaap:ConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001960262 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001960262 LUDG:CommonStockIssuableMember 2024-01-01 2024-03-31 0001960262 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001960262 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001960262 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001960262 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001960262 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001960262 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001960262 us-gaap:ConvertiblePreferredStockMember 2024-03-31 0001960262 us-gaap:CommonStockMember 2024-03-31 0001960262 LUDG:CommonStockIssuableMember 2024-03-31 0001960262 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001960262 us-gaap:RetainedEarningsMember 2024-03-31 0001960262 us-gaap:ConvertiblePreferredStockMember 2023-03-31 0001960262 us-gaap:CommonStockMember 2023-03-31 0001960262 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001960262 us-gaap:RetainedEarningsMember 2023-03-31 0001960262 2023-03-31 0001960262 2024-01-01 2024-12-31 0001960262 2023-01-01 2023-12-31 0001960262 LUDG:NotePayableOneMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableOneMember 2024-03-31 0001960262 LUDG:NotePayableOneMember 2023-12-31 0001960262 LUDG:NotePayableTwoMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableTwoMember 2024-03-31 0001960262 LUDG:NotePayableTwoMember 2023-12-31 0001960262 LUDG:NotePayableThreeMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableThreeMember 2024-03-31 0001960262 LUDG:NotePayableThreeMember 2023-12-31 0001960262 LUDG:NotePayableFourMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableFourMember 2024-03-31 0001960262 LUDG:NotePayableFourMember 2023-12-31 0001960262 LUDG:NotePayableFiveMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableFiveMember 2024-03-31 0001960262 LUDG:NotePayableFiveMember 2023-12-31 0001960262 LUDG:NotePayableSixMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableSixMember 2024-03-31 0001960262 LUDG:NotePayableSixMember 2023-12-31 0001960262 LUDG:NotePayableSevenMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableSevenMember 2024-03-31 0001960262 LUDG:NotePayableSevenMember 2023-12-31 0001960262 LUDG:NotePayableEightMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableEightMember 2024-03-31 0001960262 LUDG:NotePayableEightMember 2023-12-31 0001960262 LUDG:NotePayableNineMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableNineMember 2024-03-31 0001960262 LUDG:NotePayableNineMember 2023-12-31 0001960262 LUDG:NotePayableTenMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableTenMember 2024-03-31 0001960262 LUDG:NotePayableTenMember 2023-12-31 0001960262 LUDG:NotePayableElevenMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableElevenMember 2024-03-31 0001960262 LUDG:NotePayableElevenMember 2023-12-31 0001960262 LUDG:NotePayableTwelveMember 2024-01-01 2024-03-31 0001960262 LUDG:NotePayableTwelveMember 2024-03-31 0001960262 LUDG:NotePayableTwelveMember 2023-12-31 0001960262 LUDG:ConvertibleNotesPayableOneMember 2024-01-01 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableOneMember 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableOneMember 2023-12-31 0001960262 LUDG:ConvertibleNotesPayableTwoMember 2024-01-01 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableTwoMember 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableTwoMember 2023-12-31 0001960262 LUDG:ConvertibleNotesPayableThreeMember 2024-01-01 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableThreeMember 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableThreeMember 2023-12-31 0001960262 LUDG:ConvertibleNotesPayableFourMember 2024-01-01 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableFourMember 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableFourMember 2023-12-31 0001960262 LUDG:ConvertibleNotesPayableFiveMember 2024-01-01 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableFiverMember 2024-01-01 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableFiverMember 2024-03-31 0001960262 LUDG:ConvertibleNotesPayableFiverMember 2023-12-31 0001960262 srt:MinimumMember 2024-01-01 2024-03-31 0001960262 srt:MaximumMember 2024-01-01 2024-03-31 iso4217:USD shares iso4217:USD shares pure false 2024 Q1 --12-31 0001960262 false P5Y 10-Q true 2024-03-31 333-271439 Ludwig Enterprises, Inc. NV 61-1133438 1749 Victorian Avenue #C-350 Sparks NV 89431 786 235-9026 No Yes true Non-accelerated Filer false false 159019808 345470 108335 4133 4133 349603 112468 349603 112468 279159 204024 1270009 1270009 398000 100000 50000 1997168 1574033 1997168 1574033 7000000 7000000 0.001 0.001 7000000 7000000 7000000 7000000 7000 7000 1250000000 1250000000 0.001 0.001 155464808 155464808 155464808 155464808 155463 155463 747750 3295584 2618454 -5853362 -4242482 -1647565 -1461565 349603 112468 13047 368180 410504 42982 410016 411162 820520 -398115 -820520 -520000 7635 2572 -8000 -152737 -1212765 -155309 -1610880 -975829 -1610880 -975829 -0.01 -0.00 155464808 316055485 7000000 7000 155464808 155463 2618454 -4242482 -1461565 1475000 227500 227750 2080000 520000 520000 677130 677130 -1610880 -1610880 7000000 7000 155464808 155463 3555000 747750 3295584 -5853362 -1647565 7000000 7000 315188929 315188 637577 -1785932 -826167 1000000 1000 369000 370000 490000 490 175910 176400 -975829 -975829 7000000 7000 316678929 316678 1182487 -2761761 -1255596 -1610880 -975829 227750 176400 677130 370000 8000 152737 520000 -23865 75135 2672 -102865 -297885 290000 70000 50000 340000 70000 237135 -227885 108335 516195 345470 288310 15000 30000 Note 1–- Organization and Nature of Operations Organization and Nature of Operations Ludwig Enterprises, Inc. (collectively, “we,” “us,” “our” or the “Company”), a Nevada Corporation (incorporated February 2006). The Company is currently seeking to develop products and services through the use of cutting-edge technologies in the health care industry. Formation of Subsidiaries On May 18, 2022, the Company formed mRNA for Life, Inc. (“mRNA”), a Wyoming corporation, which is a wholly-owned subsidiary of the Company. mRNA is expected to produce supplements to address clinical diagnoses from mRNA cheek swabs. On November 18, 2022, the Company formed Precision Genomics, Inc. (“PGI”), a Wyoming corporation, which is a wholly-owned subsidiary of the Company. PGI will be developing proprietary medical artificial intelligence (“AI”) technology that uses mRNA inflammatory language to potentially capture an inflammatory snapshot of disease and the body’s response to treatment. On June 6, 2023, the Company formed Exousia Ai, Inc. (“EXO”), a Wyoming corporation, which is a wholly-owned subsidiary of the Company. EXO was formed to focus on studying the expression of differentially expressed mRNA genes in various chronic inflammatory diseases. Liquidity, Going Concern and Management’s Plans These financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the three months ended March 31, 2024, the Company had: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Net loss of $1,610,880; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Net cash used in operations was $102,865 </td></tr></table> Additionally, at March 31, 2024, the Company had: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Accumulated deficit of $5,853,362</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Stockholders’ deficit of $1,647,565; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Working capital deficit of $1,647,565</td></tr></table> The Company has cash on hand of $345,470 at March 31, 2024. The Company does not expect to generate sufficient revenues and positive cash flows from operations to meet its current obligations. However, the Company may seek to raise debt or equity-based capital at favorable terms, though such terms are not certain. These factors create substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period subsequent to the date that these financial statements are issued. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. Management’s strategic plans include the following: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Execute business operations more fully during the year ended December 31, 2024,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Seek out strategic acquisitions of health care technology; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Explore prospective partnership opportunities </td></tr></table> 1610880 102865 5853362 1647565 345470 Note 2–- Summary of Significant Accounting Policies Basis of Presentation The Company prepares its financial statements in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and accordance with accounting principles generally accepted in the United States of America (“GAAP”). The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these unaudited interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended December 31, 2023, contained in the Company’s Form 10-K filed with the SEC on April 16, 2023. Principles of Consolidation These consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of the Company and its wholly owned subsidiaries mRNA and EXO. All intercompany transactions and balances have been eliminated. Use of Estimates Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances. Significant estimates during the three months ended March 31, 2024 and 2023 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets. Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements. ASC 820 provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td>Level 1–- Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td>Level 2–- Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td>Level 3–-Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.</td></tr></table> The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist us in determining fair value, as appropriate. Although the Company believes that the recorded fair value of our financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values. The Company’s financial instruments are carried at historical cost. At March 31, 2024 and December 31, 2023, respectively, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. ASC 825-10 ”Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (“fair value option”). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding financial instruments. Cash and Cash Equivalents and Concentration of Credit Risk For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. At March 31, 2024 and December 31, 2023, respectively, the Company did not have any cash equivalents. The Company is exposed to credit risk on its cash and cash equivalents in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000. At March 31, 2024 and December 31, 2023, the Company’s cash balances exceeded FDIC insured limits by $45,000 and $0, respectively. The Company did not have any losses on cash in excess of the insured FDIC limit. Revenue recognition Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">identify the contract with a customer;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">identify the performance obligations in the contract;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">determine the transaction price;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">allocate the transaction price to performance obligations in the contract; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">recognize revenue as the performance obligation is satisfied. </td></tr></table> Research and Development The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $42,982 and $410,016 for the three months ended March 31, 2024 and 2023, respectively. Advertising Costs Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations. The Company recognized $10,451 and $69,856 in marketing and advertising costs during the three months ended March 31, 2024 and 2023, respectively. Stock-Based Compensation The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options and common stock warrant. The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. When determining fair value, the Company considers the following assumptions in the Black-Scholes model: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Exercise price,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Expected dividends,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Expected volatility,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Risk-free interest rate; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Expected life of option </td></tr></table> Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. Basic and Diluted Earnings (Loss) per Share Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible preferred stock, convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. At March 31, 2024 and 2023, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity securities: Potentially dilutive equity securities <table cellpadding="0" cellspacing="0" id="xdx_303_134_zKc3WI3OviLi" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-align: center; text-indent: -10pt"> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid">March 31, 2024</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="width: 58%; padding-left: 10pt; text-indent: -10pt"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt">Convertible Preferred Stock</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_c20240101__20240331_z1DrKLJF0cWd" style="text-align: right" title="Convertible Preferred Stock">700,000,000</td> <td> </td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_c20230101__20231231_z8BOuDoe4od4" style="text-align: right" title="Convertible Preferred Stock">700,000,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Warrant</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zlOwgKinGncf" style="border-bottom: black 2.25pt double; text-align: right" title="Grant">2,604,667</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_z3YIxyenu80c" style="border-bottom: black 2.25pt double; text-align: right" title="Grant">— </td> <td> </td></tr> </table> Each share of preferred stock (7,000,000 shares) is convertible into 100 shares of common stock. New Accounting Standard Adopted In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. In June 2022, the FASB issued ASU 2022-03, ASC Subtopic “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. These amendments clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments in this update are effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements. This guidance was adopted on January 1, 2024. The adoption of ASU 2022-03 did not have a material impact on the Company's consolidated financial statements. Basis of Presentation The Company prepares its financial statements in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and accordance with accounting principles generally accepted in the United States of America (“GAAP”). The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these unaudited interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended December 31, 2023, contained in the Company’s Form 10-K filed with the SEC on April 16, 2023. Principles of Consolidation These consolidated financial statements have been prepared in accordance with U.S. GAAP and include the accounts of the Company and its wholly owned subsidiaries mRNA and EXO. All intercompany transactions and balances have been eliminated. Use of Estimates Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances. Significant estimates during the three months ended March 31, 2024 and 2023 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets. Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements. ASC 820 provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td>Level 1–- Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td>Level 2–- Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td>Level 3–-Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.</td></tr></table> The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist us in determining fair value, as appropriate. Although the Company believes that the recorded fair value of our financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values. The Company’s financial instruments are carried at historical cost. At March 31, 2024 and December 31, 2023, respectively, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. ASC 825-10 ”Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (“fair value option”). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding financial instruments. Cash and Cash Equivalents and Concentration of Credit Risk For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. At March 31, 2024 and December 31, 2023, respectively, the Company did not have any cash equivalents. The Company is exposed to credit risk on its cash and cash equivalents in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000. At March 31, 2024 and December 31, 2023, the Company’s cash balances exceeded FDIC insured limits by $45,000 and $0, respectively. The Company did not have any losses on cash in excess of the insured FDIC limit. 45000 0 Revenue recognition Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements: <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">identify the contract with a customer;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">identify the performance obligations in the contract;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">determine the transaction price;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">allocate the transaction price to performance obligations in the contract; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: justify">recognize revenue as the performance obligation is satisfied. </td></tr></table> Research and Development The Company accounts for research and development costs in accordance with ASC subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $42,982 and $410,016 for the three months ended March 31, 2024 and 2023, respectively. Advertising Costs Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations. The Company recognized $10,451 and $69,856 in marketing and advertising costs during the three months ended March 31, 2024 and 2023, respectively. 10451 69856 Stock-Based Compensation The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options and common stock warrant. The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. When determining fair value, the Company considers the following assumptions in the Black-Scholes model: <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Exercise price,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Expected dividends,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Expected volatility,</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Risk-free interest rate; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"> ●</td><td style="text-align: justify">Expected life of option </td></tr></table> Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. Basic and Diluted Earnings (Loss) per Share Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible preferred stock, convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. At March 31, 2024 and 2023, respectively, the Company had the following common stock equivalents, which are potentially dilutive equity securities: Potentially dilutive equity securities <table cellpadding="0" cellspacing="0" id="xdx_303_134_zKc3WI3OviLi" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-align: center; text-indent: -10pt"> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid">March 31, 2024</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="width: 58%; padding-left: 10pt; text-indent: -10pt"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt">Convertible Preferred Stock</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_c20240101__20240331_z1DrKLJF0cWd" style="text-align: right" title="Convertible Preferred Stock">700,000,000</td> <td> </td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_c20230101__20231231_z8BOuDoe4od4" style="text-align: right" title="Convertible Preferred Stock">700,000,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Warrant</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zlOwgKinGncf" style="border-bottom: black 2.25pt double; text-align: right" title="Grant">2,604,667</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_z3YIxyenu80c" style="border-bottom: black 2.25pt double; text-align: right" title="Grant">— </td> <td> </td></tr> </table> Each share of preferred stock (7,000,000 shares) is convertible into 100 shares of common stock. Potentially dilutive equity securities <table cellpadding="0" cellspacing="0" id="xdx_303_134_zKc3WI3OviLi" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="padding-left: 10pt; text-align: center; text-indent: -10pt"> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid">March 31, 2024</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2023</td></tr> <tr style="vertical-align: bottom"> <td style="width: 58%; padding-left: 10pt; text-indent: -10pt"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-indent: -10pt">Convertible Preferred Stock</td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_c20240101__20240331_z1DrKLJF0cWd" style="text-align: right" title="Convertible Preferred Stock">700,000,000</td> <td> </td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_c20230101__20231231_z8BOuDoe4od4" style="text-align: right" title="Convertible Preferred Stock">700,000,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-indent: -10pt">Warrant</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zlOwgKinGncf" style="border-bottom: black 2.25pt double; text-align: right" title="Grant">2,604,667</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_z3YIxyenu80c" style="border-bottom: black 2.25pt double; text-align: right" title="Grant">— </td> <td> </td></tr> </table> 700000000 700000000 2604667 New Accounting Standard Adopted In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. In June 2022, the FASB issued ASU 2022-03, ASC Subtopic “Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. These amendments clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments in this update are effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements. This guidance was adopted on January 1, 2024. The adoption of ASU 2022-03 did not have a material impact on the Company's consolidated financial statements. Note 3 – Notes Payable and Convertible Notes Payable Notes Payable - Net Notes payable are summarized as follows: Summary of notes payable <table cellpadding="0" cellspacing="0" id="xdx_305_134_zJg1vg1t9qni" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable and Convertible Notes Payable (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Maturity</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Interest</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">March 31,</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">December 31,</td></tr> <tr> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Issue Date</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Date</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Rate</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Collateral</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2023</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zquKXgWW9Npk" style="white-space: nowrap; vertical-align: bottom; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">June 2012</td> <td style="white-space: nowrap; vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zoxVpY4QsAu6" style="white-space: nowrap; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zTV4iCaA7Bl8" style="white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zFvIU631ybT1" style="white-space: nowrap; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zfAckxxkeK56" style="white-space: nowrap; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">6,240</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zChtsiYrWJ1h" style="white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">6,240</td></tr> <tr style="background-color: White"> <td id="xdx_98C_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zfFjMw7VKnmi" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">May 2014</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zVng7pHOGLcj" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zH209jWo3QD" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zBjAYzexMs5b" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_z1xS6Usws741" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">3,456</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zmAq5Vb9YPK4" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">3,456</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zPHm3DgFZGK" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">June 2016</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zZ0aVnZZEwS8" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zcSPD1CkCeOe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zd0pda6qOtEi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_z0EHFS8yTebl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">38,216</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zIUvtbkNQDll" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">38,216</td></tr> <tr style="background-color: White"> <td id="xdx_98F_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zX36OqEv6ol9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">January 2017</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zjt24HK8tET9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zpEh5PgMNMCd" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_ziqXmfDFQqzd" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zYQOYqpjfgC3" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">7,344</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_z5AmsvcWilP8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">7,344</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zYi9UIKwQ1ja" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">November 2020</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zutpu5YFBYDd" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zxvHOB22VLsl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">12%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_z2d5tinq8ly9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zI7BrqQRNCQl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">46,480</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zACOkaG1ARsj" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">46,480</td></tr> <tr style="background-color: White"> <td id="xdx_983_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_z1B8MlwMN1M6" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">March 2021</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_z9OgklPDV9gc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_z0IG3qsn8So6" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_zA7rsjAC0PBc" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_zZ1Wj1aSMdn5" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">5,400</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_zOBfq0wtSYM6" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">5,400</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zC3JLisZFUz8" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">November 2021</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zu9U0tNEaCwe" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zGVl2a1mYYQ8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98D_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zLgwcNLYdw2g" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zWnv5Rcx6rdc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">250,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zrWtVBB0wrSc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">250,000</td></tr> <tr style="background-color: White"> <td id="xdx_984_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zc5DqIPXcuf1" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">February 2022</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zVeqXQQEDnQc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_z8SUd3Mwci63" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zZtrFtf8CFB2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zzyAOslXQboc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zoLORDxGE5dj" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">150,000</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zo1z2Z9gtsI2" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">August 2023</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zgvoBWVJwc2d" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">August 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zbBnstp1ByKi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zz43s7vEyKE1" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zZ6xZYHWjVUh" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">122,873</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_z1s8A56dQca9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">122,873</td></tr> <tr style="background-color: White"> <td id="xdx_981_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zo7ubKbR2dd7" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">January 2023 (1)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_989_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zq81kfxqWBy9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zsHE6qqZduW2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zEVHQPCjzj4j" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_z67KWEJST1w6" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zQeSLttyEAz3" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zcJSNiow8oYg" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">October 2022 (1)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zS4GOAkM4fW4" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zZZpgghiF2Oi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_989_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zCoKt6fFeJ9h" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zH0ldXKn9LE2" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">440,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zM28GQ0xSnYe" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">440,000</td></tr> <tr style="background-color: White"> <td id="xdx_984_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_z2AP18MW42Kb" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">November 2022 (1)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_ziTprcKQJGq7" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_zlbKAKha6aEe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zaoCFotmUETc" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_zcJC5d2PxJqh" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_z03xExsq5uu" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Notes payable</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_c20240331_z0rxsb30jlXg" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">1,270,009</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20231231_znmD1QuGhpZe" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">1,270,009</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 6%; padding-top: 1.8pt; text-align: center">(1)</td> <td style="width: 94%; padding-top: 1.8pt; text-align: justify">In November 2023, the convertible notes were amended to remove the conversion features and the Company reclassified $640,000 from convertible notes to notes payable.</td></tr> </table> Convertible Notes Payable - Net The Company had the following activity related to its convertible notes payable: Convertible notes payable, net <table cellpadding="0" cellspacing="0" id="xdx_303_134_zP9MlcRYy0k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable and Convertible Notes Payable (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; padding-left: 5.4pt">Balance - December 31, 2023</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iS_c20240101__20240331_zKT0MjIZ6sZ6" style="width: 18%; text-align: right" title="Balance - December 31, 2023">100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Proceeds (face amount of note)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ProceedsFromNotesPayable_c20240101__20240331_zsRDtJjI4A65" style="text-align: right" title="Proceeds (face amount of note)">300,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Guaranteed Interest recorded to convertible note payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GuaranteedInterestRecordedToConvertibleNotePayable_c20240101__20240331_zAnue0dVtPqf" style="text-align: right" title="Guaranteed Interest recorded to convertible note payable">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Original issue debt discount</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--DebtDiscountBeneficialConversionFeatureNote_c20240101__20240331_zfPkcd0axhv2" style="text-align: right" title="Original issue debt discount">(10,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Guaranteed interest – debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--GuaranteedInterestDebtDscount_c20240101__20240331_zUgN9wIjkRa9" style="border-bottom: Black 1pt solid; text-align: right">(5,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Amortization of debt discount </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--AccretionOfDebtDiscountRecordedToInterestExpense_c20240101__20240331_zAKsIPai4AX1" style="text-align: right" title="Accretion of debt discount recorded to interest expense">8,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Balance – March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iE_c20240101__20240331_z055t8z9uOU1" style="border-bottom: Black 2.5pt double; text-align: right">398,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Convertible Notes Payable are summarized as follows: Summary Of Convertible Notes Payable <table cellpadding="0" cellspacing="0" id="xdx_30B_134_zGE9APwhvsi6" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable and Convertible Notes Payable (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Maturity</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Interest</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">March 31,</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">December 31,</td></tr> <tr> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Issue Date</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Date</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Rate</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Collateral</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2023</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zrNNnMizmr2l" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">October 2023</td> <td style="white-space: nowrap; vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_989_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zSFwIODL63a2" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">October 2024</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zkvnMDPKIRZk" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_znIklztjtH34" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_98C_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zzQK3ddzB4Vl" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zPlVm3zIEgBg" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_980_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zcGbu7twjQN8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">February 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zw7oll6qBXHk" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">May 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zSPmTOkk4dNb" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">10%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_ztTh5cjmCAc5" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zOhnW7ZFJce" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">55,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zk9y5MKWzn8a" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zK1MRTYtgFZ" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">March 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zx3i6Gua80jb" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">March 2025</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zroRT17AQJ61" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zU5IoOvFQST7" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zwf8RX0C6cab" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">150,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zS5o5hfsQ7ma" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: White"> <td id="xdx_989_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zqFPt9lXsSi9" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="issue date">March 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zOrSiuFYj5A4" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">March 2025</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zVbW2vmcUCF4" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_z8oXkYmQfIal" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zcW6iroYdIHe" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zGgjp1HkvrR1" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiveMember_zjaAsIPibbV8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="issue date">March 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zKF2iHPTVFLl" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">March 2025</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zZSVe0zurb88" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zP1ETdMuMXjd" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zlX14mdeFMji" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zDuOgaw47zK" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20240331_zuT9NI9T9ZG9" style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">405,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20231231_zB0iPM9gv9Wl" style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Less: unamortized debt discount</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240331_zsPT3g6Ixop8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Unamortized debt discount">(7,000)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231231_zx1sBMgceiG8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Convertible notes payable – net</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_ecustom--ConvertibleNotesPayableNet_iI_c20240331_ztEqite8ErF8" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">398,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_98E_ecustom--ConvertibleNotesPayableNet_iI_c20231231_zW87aRlcgp3" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td></tr> </table> Notes Issued in 2024 In February, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated February 12, 2024, in the principal amount of $50,000. The Note was funded by the Investor on February 15, 2024, with the Company receiving funding of $40,000, net of OID of $15,000, including guaranteed interest of 10% per calendar year, or $5,000. The Note matures on May 12, 2024. Only upon an event of default that shall not have been cured, the Note is convertible into shares of the Company’s common stock at any time at a conversion price equal to the lowest traded price of the Common Stock during the thirty (30) business days prior to the relevant notice of conversion; provided, however, that the Investor may not convert the Note to the extent that such conversion would result in the investor’s beneficial ownership of the Company’s common stock being in excess of 9.99% of the Company’s then-issued and outstanding common stock. On March 28, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated March 31, 2024, in the principal amount of $150,000 with an interest rate of 8% per annum. The Note matures on March 31,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges. On March 28, 2024, the Company entered into a second securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated March 31, 2024, in the principal amount of $50,000 with an interest rate of 8% per annum. The Note matures on March 31,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges. On March 28, 2024, the Company entered into a second securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated March 31, 2024, in the principal amount of $50,000 with an interest rate of 8% per annum. The Note matures on March 31,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges. Inducements In March 2024, the Company recorded 2,080,000 shares of common stock issuable as inducements to 7 individuals for the extension of 7 promissory notes to July 1, 2024, which shares were valued at $0.25 per share. The Company recorded $520,000 as inducement expense. Summary of notes payable <table cellpadding="0" cellspacing="0" id="xdx_305_134_zJg1vg1t9qni" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable and Convertible Notes Payable (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Maturity</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Interest</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">March 31,</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">December 31,</td></tr> <tr> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Issue Date</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Date</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Rate</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Collateral</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2023</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zquKXgWW9Npk" style="white-space: nowrap; vertical-align: bottom; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">June 2012</td> <td style="white-space: nowrap; vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zoxVpY4QsAu6" style="white-space: nowrap; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zTV4iCaA7Bl8" style="white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zFvIU631ybT1" style="white-space: nowrap; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zfAckxxkeK56" style="white-space: nowrap; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">6,240</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableOneMember_zChtsiYrWJ1h" style="white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">6,240</td></tr> <tr style="background-color: White"> <td id="xdx_98C_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zfFjMw7VKnmi" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">May 2014</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zVng7pHOGLcj" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zH209jWo3QD" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zBjAYzexMs5b" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_z1xS6Usws741" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">3,456</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableTwoMember_zmAq5Vb9YPK4" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">3,456</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zPHm3DgFZGK" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">June 2016</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zZ0aVnZZEwS8" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zcSPD1CkCeOe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zd0pda6qOtEi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_z0EHFS8yTebl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">38,216</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableThreeMember_zIUvtbkNQDll" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">38,216</td></tr> <tr style="background-color: White"> <td id="xdx_98F_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zX36OqEv6ol9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">January 2017</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zjt24HK8tET9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zpEh5PgMNMCd" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_ziqXmfDFQqzd" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_zYQOYqpjfgC3" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">7,344</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableFourMember_z5AmsvcWilP8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">7,344</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zYi9UIKwQ1ja" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">November 2020</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zutpu5YFBYDd" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zxvHOB22VLsl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">12%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_z2d5tinq8ly9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zI7BrqQRNCQl" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">46,480</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableFiveMember_zACOkaG1ARsj" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">46,480</td></tr> <tr style="background-color: White"> <td id="xdx_983_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_z1B8MlwMN1M6" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">March 2021</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_z9OgklPDV9gc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_z0IG3qsn8So6" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_zA7rsjAC0PBc" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_zZ1Wj1aSMdn5" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">5,400</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableSixMember_zOBfq0wtSYM6" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">5,400</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zC3JLisZFUz8" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">November 2021</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zu9U0tNEaCwe" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zGVl2a1mYYQ8" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98D_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zLgwcNLYdw2g" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zWnv5Rcx6rdc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">250,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableSevenMember_zrWtVBB0wrSc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">250,000</td></tr> <tr style="background-color: White"> <td id="xdx_984_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zc5DqIPXcuf1" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">February 2022</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zVeqXQQEDnQc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_z8SUd3Mwci63" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zZtrFtf8CFB2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zzyAOslXQboc" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">150,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableEightMember_zoLORDxGE5dj" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">150,000</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zo1z2Z9gtsI2" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">August 2023</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zgvoBWVJwc2d" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">August 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zbBnstp1ByKi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zz43s7vEyKE1" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zZ6xZYHWjVUh" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">122,873</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_z1s8A56dQca9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">122,873</td></tr> <tr style="background-color: White"> <td id="xdx_981_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zo7ubKbR2dd7" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">January 2023 (1)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_989_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zq81kfxqWBy9" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zsHE6qqZduW2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zEVHQPCjzj4j" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_z67KWEJST1w6" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableTenMember_zQeSLttyEAz3" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zcJSNiow8oYg" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">October 2022 (1)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zS4GOAkM4fW4" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zZZpgghiF2Oi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_989_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zCoKt6fFeJ9h" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zH0ldXKn9LE2" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">440,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableElevenMember_zM28GQ0xSnYe" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">440,000</td></tr> <tr style="background-color: White"> <td id="xdx_984_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_z2AP18MW42Kb" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">November 2022 (1)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_ziTprcKQJGq7" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">July 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_zlbKAKha6aEe" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">0%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_983_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableNineMember_zaoCFotmUETc" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral Description">Unsecured</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--OtherNotesPayableCurrent_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_zcJC5d2PxJqh" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--NotePayableTwelveMember_z03xExsq5uu" style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">100,000</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Notes payable</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_986_eus-gaap--OtherNotesPayableCurrent_iI_c20240331_z0rxsb30jlXg" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">1,270,009</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_iI_c20231231_znmD1QuGhpZe" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes Payable">1,270,009</td></tr> </table> June 2012 July 2024 0.08 Unsecured 6240 6240 May 2014 July 2024 0.08 Unsecured 3456 3456 June 2016 July 2024 0.08 Unsecured 38216 38216 January 2017 July 2024 0.08 Unsecured 7344 7344 November 2020 July 2024 0.12 Unsecured 46480 46480 March 2021 July 2024 0.08 Unsecured 5400 5400 November 2021 July 2024 0 Unsecured 250000 250000 February 2022 July 2024 0 Unsecured 150000 150000 August 2023 August 2024 0.08 Unsecured 122873 122873 January 2023 (1) July 2024 0 Unsecured 100000 100000 October 2022 (1) July 2024 0 Unsecured 440000 440000 November 2022 (1) July 2024 0 Unsecured 100000 100000 1270009 1270009 Convertible notes payable, net <table cellpadding="0" cellspacing="0" id="xdx_303_134_zP9MlcRYy0k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable and Convertible Notes Payable (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; padding-left: 5.4pt">Balance - December 31, 2023</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iS_c20240101__20240331_zKT0MjIZ6sZ6" style="width: 18%; text-align: right" title="Balance - December 31, 2023">100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Proceeds (face amount of note)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ProceedsFromNotesPayable_c20240101__20240331_zsRDtJjI4A65" style="text-align: right" title="Proceeds (face amount of note)">300,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Guaranteed Interest recorded to convertible note payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GuaranteedInterestRecordedToConvertibleNotePayable_c20240101__20240331_zAnue0dVtPqf" style="text-align: right" title="Guaranteed Interest recorded to convertible note payable">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Original issue debt discount</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--DebtDiscountBeneficialConversionFeatureNote_c20240101__20240331_zfPkcd0axhv2" style="text-align: right" title="Original issue debt discount">(10,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Guaranteed interest – debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--GuaranteedInterestDebtDscount_c20240101__20240331_zUgN9wIjkRa9" style="border-bottom: Black 1pt solid; text-align: right">(5,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Amortization of debt discount </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--AccretionOfDebtDiscountRecordedToInterestExpense_c20240101__20240331_zAKsIPai4AX1" style="text-align: right" title="Accretion of debt discount recorded to interest expense">8,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Balance – March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iE_c20240101__20240331_z055t8z9uOU1" style="border-bottom: Black 2.5pt double; text-align: right">398,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 100000 300000 5000 -10000 -5000 8000 398000 Summary Of Convertible Notes Payable <table cellpadding="0" cellspacing="0" id="xdx_30B_134_zGE9APwhvsi6" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable and Convertible Notes Payable (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Maturity</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Interest</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">March 31,</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">December 31,</td></tr> <tr> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Issue Date</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Date</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Rate</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Collateral</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2023</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zrNNnMizmr2l" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">October 2023</td> <td style="white-space: nowrap; vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_989_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zSFwIODL63a2" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">October 2024</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zkvnMDPKIRZk" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_znIklztjtH34" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_98C_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zzQK3ddzB4Vl" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td> <td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableOneMember_zPlVm3zIEgBg" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_980_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zcGbu7twjQN8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">February 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zw7oll6qBXHk" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">May 2024</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zSPmTOkk4dNb" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">10%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_ztTh5cjmCAc5" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zOhnW7ZFJce" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">55,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableTwoMember_zk9y5MKWzn8a" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zK1MRTYtgFZ" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Issue date">March 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_985_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zx3i6Gua80jb" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">March 2025</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zroRT17AQJ61" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zU5IoOvFQST7" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zwf8RX0C6cab" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">150,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_986_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableThreeMember_zS5o5hfsQ7ma" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: White"> <td id="xdx_989_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zqFPt9lXsSi9" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="issue date">March 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98A_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zOrSiuFYj5A4" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">March 2025</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_987_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zVbW2vmcUCF4" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_z8oXkYmQfIal" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zcW6iroYdIHe" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFourMember_zGgjp1HkvrR1" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--IssueDateDescrption_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiveMember_zjaAsIPibbV8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="issue date">March 2024</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_980_ecustom--MaturityDate_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zKF2iHPTVFLl" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Maturity Date">March 2025</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zZSVe0zurb88" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Interest rate">8%</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_984_ecustom--CollateralDescription_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zP1ETdMuMXjd" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Collateral description">Unsecured</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zlX14mdeFMji" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesPayableFiverMember_zDuOgaw47zK" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_982_eus-gaap--LongTermDebt_iI_c20240331_zuT9NI9T9ZG9" style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">405,000</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_987_eus-gaap--LongTermDebt_iI_c20231231_zB0iPM9gv9Wl" style="border-top: Black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Less: unamortized debt discount</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240331_zsPT3g6Ixop8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Unamortized debt discount">(7,000)</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231231_zx1sBMgceiG8" style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">-</td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">Convertible notes payable – net</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98E_ecustom--ConvertibleNotesPayableNet_iI_c20240331_ztEqite8ErF8" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">398,000</td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">$</td> <td id="xdx_98E_ecustom--ConvertibleNotesPayableNet_iI_c20231231_zW87aRlcgp3" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100,000</td></tr> </table> October 2023 October 2024 0.08 Unsecured 100000 100000 February 2024 May 2024 0.10 Unsecured 55000 March 2024 March 2025 0.08 Unsecured 150000 March 2024 March 2025 0.08 Unsecured 50000 March 2024 March 2025 0.08 Unsecured 50000 405000 100000 -7000 398000 100000 Note 4 – Commitments and Contingencies On September 5, 2023, we entered into an employment agreement with Marvin S. Hausman, M.D., pursuant to which Dr. Hausman serves as our Chief Executive Officer. Under his employment agreement, we will pay Dr. Hausman $5,000 per month. In addition, we will pay Dr. Hausman an amount equal to 10% of gross sales revenues attributable to Dr. Hausman’s efforts, in perpetuity. On September 5, 2023, we entered into an employment agreement with Thomas Terwilliger, pursuant to which Mr. Terwilliger serves as our Chief Operating Officer, Treasurer and Secretary. Under his employment agreement, we will pay Mr. Terwilliger $5,000 per month. In addition, we will pay Mr. Terwilliger an amount equal to 10% of gross sales revenues attributable to Mr. Terwilliger’s efforts, in perpetuity. On November 28, 2023, Mr. Terwilliger resigned as Chief Operating Officer, but continues to provide limited services to the company on an outsourced basis. On November 15, 2023, we entered into a Financial Advisory Services Agreement with EverAsia Financial Group, Inc., a financial consulting firm owned by Scott J. Silverman, who, in conjunction with the execution the CFO Agreement, was appointed as our Chief Financial Officer. Under the CFO Agreement, the Company is obligated to make monthly payments of $8,750, as follows: Beginning from the execution date of the CFO Agreement and continuing until the Company raises $750,000 in equity or debt financing (the “Accrual Period”), the Company is obligated to make the monthly payments described in the following table: Schedule of monthly payment <table cellpadding="0" cellspacing="0" id="xdx_30E_134_zE2nihCdS8gd" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details)"> <tr style="vertical-align: top"> <td style="border: Black 1pt solid; width: 34%; padding-right: 5.75pt; text-align: justify">Funds Raised</td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 33%; padding-right: 5.75pt; text-align: justify">Paid Monthly</td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 33%; padding-right: 5.75pt; text-align: justify">Accrued Monthly</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; text-align: justify">$0 – $250,000</td> <td id="xdx_982_ecustom--MonthlyPayment_c20240101__20240331_zvjmavXKwDGk" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Monthly payment">$3,750</td> <td id="xdx_985_ecustom--AccruedMonthly_c20240101__20240331_zyfPQbke0mHa" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Accrued Monthly">$5,000</td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; text-align: justify">$250,000 – $750,000</td> <td id="xdx_98F_ecustom--MonthlyPaymentSecond_c20240101__20240331_zBsAfC5ZN0pa" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Second Monthly payment">$5,000</td> <td id="xdx_981_ecustom--SecondAccruedMonthly_c20240101__20240331_z750qrsqE7d5" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Second Accrued Monthly">$3,750</td></tr> </table> Upon the Company’s raising of $750,000, it shall pay the accrued amount in cash. Thereafter, the Company shall pay the entire monthly payment without accrual. Schedule of monthly payment <table cellpadding="0" cellspacing="0" id="xdx_30E_134_zE2nihCdS8gd" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Commitments and Contingencies (Details)"> <tr style="vertical-align: top"> <td style="border: Black 1pt solid; width: 34%; padding-right: 5.75pt; text-align: justify">Funds Raised</td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 33%; padding-right: 5.75pt; text-align: justify">Paid Monthly</td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 33%; padding-right: 5.75pt; text-align: justify">Accrued Monthly</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; text-align: justify">$0 – $250,000</td> <td id="xdx_982_ecustom--MonthlyPayment_c20240101__20240331_zvjmavXKwDGk" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Monthly payment">$3,750</td> <td id="xdx_985_ecustom--AccruedMonthly_c20240101__20240331_zyfPQbke0mHa" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Accrued Monthly">$5,000</td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; text-align: justify">$250,000 – $750,000</td> <td id="xdx_98F_ecustom--MonthlyPaymentSecond_c20240101__20240331_zBsAfC5ZN0pa" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Second Monthly payment">$5,000</td> <td id="xdx_981_ecustom--SecondAccruedMonthly_c20240101__20240331_z750qrsqE7d5" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; text-align: justify" title="Second Accrued Monthly">$3,750</td></tr> </table> 0 250000 3750 5000 250000 750000 5000 3750 Note 5 – Stockholders’ Deficit The Company has two (2) classes of stock: Common Stock <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">1,250,000,000 shares authorized</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">$0.001 par value</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">Voting at 1 vote per share</td></tr></table> Preferred Stock In May 2022 and December 2022, the Company’s Articles of Incorporation, as amended, authorized the issuance of 7,000,000 shares of preferred stock which may be amended from time to time in one or more series. The Board of Directors is authorized to determine, prior to issuing any such series of preferred stock and without any vote or action by the shareholders, the rights, preferences, privileges and restrictions of the shares of such series, including dividend rights, voting rights, terms of redemption, the provisions of any purchase, retirement or sinking fund to be provided for the shares of any series, conversion and exchange rights, the preferences upon any distribution of the assets of the Company, including in the event of voluntary or involuntary liquidation, dissolution or winding up of the Company, and the preferences and relative rights among each series of preferred stock. The Board of Directors has made the following designations of its preferred stock. Series A, Convertible Preferred Stock <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>7,000,000 shares authorized.</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>$0.001 par value.</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>Conversion feature–-each share of preferred stock is convertible into 100 shares of common stock.</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>Voting–-on an as converted basis with common stock, at the applicable conversion rate (100 votes for each share of convertible preferred held).</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>Dividends–-accrued only upon declaration of the board of directors, at the applicable conversion rate.</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>Mandatorily redeemable (automatic conversion) on January 1, 2025. (See below amendment)</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 20pt"></td><td style="width: 18pt">●</td><td>Anti-dilution provision – rights exist for the period of two years after the convertible preferred shares were converted into common stock. Additionally, holders of the convertible preferred stock will have full ratchet anti-dilution protection rights at the rate of 65% calculated on a fully diluted basis. (See below amendment) </td></tr></table> In connection with the issuance of these Series A, convertible preferred shares, the Company determined that there were no provisions within ASC 815 that were met, which would require derivative liability accounting treatment. Specifically, as noted below, upon amending the terms of the Series A, convertible preferred stock, at that time, there had been no new stock issuances of any type which may have triggered the anti-dilution provision. In December 2022, the Company amended its articles of incorporation related to certain terms of its Series A, convertible preferred stock. At that time, the Company, along with approval from its convertible preferred stockholders agreed to remove provisions related to mandatory redemption as well as anti-dilution rights. At March 31, 2024 and December 31, 2023, the Company had 7,000,000 shares issued and outstanding. See below for related issuances. Equity Transactions for fiscal year 2024 During the three months ended March 31, 2024, the Company recorded 3,555,000 shares of common stock issuable as follows: <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px">●</td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify">225,000 shares of common stock to three individuals as bonuses for their services valued at $0.29 per share, the closing price on the date of issue as quoted on OTCMarkets.com, for a total of $65,250.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">1,250,000 shares of common stock to an individual for his services. Such shares of common stock were issued as compensation (250,000 shares pursuant to a consulting agreement and 1,000,000 shares as a performance bonus) valued at $0.13 per share, the closing price on the date of issue as quoted on OTCMarkets.com, for a total of $162,500.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">2,080,000 shares of common stock as inducements to enter into promissory notes with the Company, valued at $0.25 per share, the closing price on the date of issue as quoted on OTCMarkets.com, for a total of $520,000</td></tr> </table> Securities Purchase Agreement On February 12, 2024, the Company entered into a Common Stock Purchase Agreement (the “Purchase Agreement”), together with a registration rights agreement (the “Registration Rights Agreement”) with an institutional investor (the “Investor”), pursuant to which the Company has the right to sell to the Investor up to $5,000,000 in shares of its common stock (“Common Stock”), subject to certain limitations. The Investor was also issued a five-year warrant (the “Warrant”) to purchase 2,604,667 shares of Common Stock (the “Warrant Shares”) with standard anti-dilution provisions and cashless exercise. Under the terms and subject to the conditions of the Purchase Agreement, the Investor is obligated to purchase up to $5,000,000 in shares of Common Stock (subject to certain limitations) from time to time over the period commencing on the date of the Purchase Agreement and ending on June 30, 2025. The price per share of Common Stock shall be eighty percent (80%) of the lowest traded price of the Common Stock for the six trading days following the closing date associated with the purchase notice delivered by the Company to the Investor. The maximum amount of each purchase notice shall be the lesser of (a) $250,000 or (b) two hundred fifty percent (250%) of the average daily trading volume during the six business days prior to the date associated with the purchase notices delivered by the Company to the Investor. The Company’s sales of shares of Common Stock to the Investor under the Purchase Agreement are limited to no more than the number of shares that would result in the beneficial ownership by the Investor and its affiliates, at any single point in time, of more than 4.99% of the then-outstanding shares of the Common Stock; provided, however, that the Investor may increase the beneficial ownership limitation up to 9.99%, at its sole discretion, upon sixty-one (61) days’ prior written notice to the Company. The Company agreed with the Investor that it will not enter into any other equity line or similar agreements without the prior consent of the Investor. Pursuant to the terms of the Registration Rights Agreement, the Company shall file a registration statement with the SEC with respect to the shares of Common Stock issuable to the Investor pursuant to the Purchase Agreement and the Warrant Shares within 20 calendar days. The Purchase Agreement and the Registration Rights Agreement contain customary representations, warranties and agreements of the Company and the Investor and customary conditions to completing future sale transactions, indemnification rights and obligations of the parties. The Company has not sold any shares to the Investor as of March 31, 2024. Note 6 – Warrants In February 2024, the Company issued 2,604,667 warrants in connection with the Purchase Agreement (Note 5), valued at $677,130. The Warrants expire five (5) years from the date of issuance. The warrants were earned and issued without recourse upon signature of the Purchase Agreement (Note 5),and recorded as a finance expense. The exercise price per warrant shall be calculated by dividing $30,000,000 by the total number of outstanding shares of common stock as of the exercise date. A summary of activity of the warrants during the three months ended March 31, 2024, is follows: Summary of activity of the warrants <table cellpadding="0" cellspacing="0" id="xdx_309_134_zVraESmlYcsk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Warrants (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Number of</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Weighted average</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Weighted average</td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Warrant</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Exercise price</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Remaining life (year)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at December 31, 2023</td> <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iS_d0_c20240101__20240331_zEu6gvifdbZ2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at December 31, 2023"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">$</td> <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20240101__20240331_zx5eePm0Uclf" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at December 31, 2023"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY0_c20240101__20240331_z5wigGkRL9vc" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at December 31, 2023">- </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Grant</td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zB3tu0BdRBRh" style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt" title="Grant"> 2,604,667 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331_z3qAnSomv1u9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Grant"> 0.19 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3_dtY_c20240101__20240331_zcs7CRY8mHvi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Grant">5.00 </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Exercised </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Cancelled</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at March 31, 2024</td> <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iE_c20240101__20240331_z3VuXyzgcGs5" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at March 31, 2024"> 2,604,667 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">$</td> <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20240101__20240331_ziSRmSdlUFmd" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at March 31, 2024"> 0.19 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zeKpqyKQQchf" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at March 31, 2024">4.87 </td></tr> </table> The intrinsic value of the warrants as of March 31, 2024, is $148,545. All of the outstanding warrants are exercisable as of March 31, 2024. Valuation The Company utilizes the Black-Scholes model to value its warrants. The Company utilized the following assumptions: <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zVYu82iZTMf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Valuation assumptions <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zHW3VvQJBNN5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Warrants (Details 1)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"></td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"></td><td style="text-align: center"> </td> <td colspan="3" style="text-align: center">Three months ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2024</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected term</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20240101__20240331_zgOt0Z69UzZf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Expected term::XDX::P5Y">5 years</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%">Expected average volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20240101__20240331_z3Qc8DK1xiH9" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Expected average volatility">338</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d0_c20240101__20240331_zKto62A2zJvb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Expected dividend yield">— </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240331_zMn2uyakdNEh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Risk-free interest rate">4.13</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> Summary of activity of the warrants <table cellpadding="0" cellspacing="0" id="xdx_309_134_zVraESmlYcsk" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Warrants (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Number of</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Weighted average</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Weighted average</td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Warrant</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Exercise price</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Remaining life (year)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at December 31, 2023</td> <td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iS_d0_c20240101__20240331_zEu6gvifdbZ2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at December 31, 2023"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">$</td> <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20240101__20240331_zx5eePm0Uclf" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at December 31, 2023"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY0_c20240101__20240331_z5wigGkRL9vc" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at December 31, 2023">- </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Grant</td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_zB3tu0BdRBRh" style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt" title="Grant"> 2,604,667 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331_z3qAnSomv1u9" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Grant"> 0.19 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3_dtY_c20240101__20240331_zcs7CRY8mHvi" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Grant">5.00 </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Exercised </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Cancelled</td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> - </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">Outstanding at March 31, 2024</td> <td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iE_c20240101__20240331_z3VuXyzgcGs5" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at March 31, 2024"> 2,604,667 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">$</td> <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20240101__20240331_ziSRmSdlUFmd" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at March 31, 2024"> 0.19 </td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"> </td> <td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zeKpqyKQQchf" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding at March 31, 2024">4.87 </td></tr> </table> -0 -0 2604667 0.19 P5Y 2604667 0.19 P4Y10M13D <p id="xdx_891_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zVYu82iZTMf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Valuation assumptions <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zHW3VvQJBNN5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Warrants (Details 1)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"></td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"></td><td style="text-align: center"> </td> <td colspan="3" style="text-align: center">Three months ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2024</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected term</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtxL_c20240101__20240331_zgOt0Z69UzZf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Expected term::XDX::P5Y">5 years</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%">Expected average volatility</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20240101__20240331_z3Qc8DK1xiH9" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Expected average volatility">338</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d0_c20240101__20240331_zKto62A2zJvb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Expected dividend yield">— </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240331_zMn2uyakdNEh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Risk-free interest rate">4.13</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> 3.38 0 0.0413 Note 7 – Subsequent Events On April 1, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated April 1, 2024, in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on April,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges. On April 1, 2024, the Company entered into a securities purchase agreement (the “SPA”), pursuant to which the Company agreed to issue to the Investor a Promissory Note (the “Note”), dated April 1, 2024, in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on April 1,2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges. On May 9, 2024, the Company paid the $50,000 OID Note entered into in February, 2024 together with $5,000 in guaranteed interest and retired the Note. On May 15, 2024, the Company entered issued a Convertible Promissory Note to an investor in the principal amount of $10,000 with an interest rate of 8% per annum. The Note matures on May 15, 2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges. On May 16, 2024, the Company entered issued a Convertible Promissory Note to an investor in the principal amount of $100,000 with an interest rate of 8% per annum. The Note matures on May 16, 2025. The principal amount of the note together with any accrued interest is convertible into common shares at any time prior or at maturity at a price of $0.10 per common share. The Note together with any accrued interest shall automatically convert into common shares at a price of $0.10 per share upon the successful uplisting of the Company’s common stock onto the NASDAQ, CBOE or NYSE American stock exchanges.